E-Bibliothek Gesundheitskompetenz des DNGK
Autorenseite: Jens-Ulrich Rüffer (Mitglied des DNGK)
Hier finden Sie die in der Datenbank des DNGK eingestellten Publikationen des genannten DNGK-Mitglieds.
6298796
J987ELTY
1
chicago-fullnote-bibliography
50
date
title
10255
https://gesundheitskompetenz.online/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A50%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%228TXKVCWR%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Clayman%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BClayman%2C%20Marla%20L.%2C%20F%26%23xFC%3Bl%26%23xF6%3Bp%20Scheibler%2C%20Jens%20Ulrich%20R%26%23xFC%3Bffer%2C%20Kai%20Wehkamp%2C%20and%20Friedemann%20Geiger.%20%26%23x201C%3BThe%20Six%20Steps%20of%20SDM%3A%20Linking%20Theory%20to%20Practice%2C%20Measurement%20and%20Implementation.%26%23x201D%3B%20%26lt%3Bi%26gt%3BBMJ%20Evidence-Based%20Medicine%26lt%3B%5C%2Fi%26gt%3B%2029%2C%20no.%202%20%28March%2021%2C%202024%29%3A%2075%26%23x2013%3B78.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjebm-2023-112289%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjebm-2023-112289%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Six%20Steps%20of%20SDM%3A%20linking%20theory%20to%20practice%2C%20measurement%20and%20implementation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marla%20L.%22%2C%22lastName%22%3A%22Clayman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%5Cu00fcl%5Cu00f6p%22%2C%22lastName%22%3A%22Scheibler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wehkamp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Geiger%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024-03-21%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjebm-2023-112289%22%2C%22ISSN%22%3A%222515-4478%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%223L4EXKAR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-05-16T07%3A09%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22FLI43PZX%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schwab%20et%20al.%22%2C%22parsedDate%22%3A%222024-02-13%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSchwab%2C%20Isabella%2C%20Till%20Dresbach%2C%20Tim%20Ohnh%5Cu00e4user%2C%20Dirk%20Horenkamp-Sonntag%2C%20Nadine%20Scholten%2C%20Andreas%20M%5Cu00fcller%2C%20Martin%20Hellmich%2C%20et%20al.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12884-024-06315-3%26%23039%3B%26gt%3BPressure%20to%20provide%20milk%20among%20mothers%20of%20very%20low%20birth%20weight%20infants%3A%20an%20explorative%20study%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BBMC%20Pregnancy%20and%20Childbirth%26lt%3B%5C%2Fi%26gt%3B%2024%2C%20no.%201%20%28February%2013%2C%202024%29%3A%20134.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pressure%20to%20provide%20milk%20among%20mothers%20of%20very%20low%20birth%20weight%20infants%3A%20an%20explorative%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabella%22%2C%22lastName%22%3A%22Schwab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Till%22%2C%22lastName%22%3A%22Dresbach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tim%22%2C%22lastName%22%3A%22Ohnh%5Cu00e4user%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%22%2C%22lastName%22%3A%22Horenkamp-Sonntag%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Scholten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Hellmich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Ernstmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antje%22%2C%22lastName%22%3A%22Hammer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friederike%22%2C%22lastName%22%3A%22Eyssel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%22%2C%22lastName%22%3A%22Kribs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliane%22%2C%22lastName%22%3A%22K%5Cu00f6berlein-Neu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katharina%22%2C%22lastName%22%3A%22Lugani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eva%22%2C%22lastName%22%3A%22Mildenberger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katja%22%2C%22lastName%22%3A%22Matthias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Sunder-Pla%5Cu00dfmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Wiesen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iris%22%2C%22lastName%22%3A%22Klein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melanie%22%2C%22lastName%22%3A%22Klein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Rupprecht%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Schleich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olaf%22%2C%22lastName%22%3A%22Beckmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anke%22%2C%22lastName%22%3A%22Kurz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Neo-MILK%22%7D%5D%2C%22abstractNote%22%3A%22Pump-dependent%20mothers%20of%20very%20low%20birth%20weight%20%28VLBW%2C%5Cu2009%26lt%3B%5Cu20091500g%29%20infants%20experience%20specific%20challenges%20achieving%20sufficient%20milk%20supply%20in%20the%20neonatal%20intensive%20care%20unit%20%28NICU%29%20and%20are%20therefore%20less%20frequently%20able%20to%20achieve%20%28exclusive%29%20breast%20milk%20feeding.%20Stress%20due%20to%20the%20limitations%20on%20participating%20in%20the%20infant%5Cu2019s%20care%20may%20contribute%20to%20this%20problem.%20Some%20explorative%20studies%20suggest%20that%20pressure%20to%20provide%20milk%20may%20be%20an%20additional%20stressor%20in%20mothers.%20However%2C%20the%20type%20of%20pressure%20to%20provide%20milk%20perceived%20by%20mothers%20of%20VLBW%20infants%20has%20rarely%20been%20examined.%22%2C%22date%22%3A%222024-02-13%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12884-024-06315-3%22%2C%22ISSN%22%3A%221471-2393%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12884-024-06315-3%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22EBMCDUNP%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222025-04-10T03%3A48%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22HF7HWR97%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ferdinandus%20et%20al.%22%2C%22parsedDate%22%3A%222023-12-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFerdinandus%2C%20J.%2C%20H.%20M%26%23xFC%3Bller%2C%20C.%20Damaschin%2C%20A.%20S.%20Jacob%2C%20J.%20Meissner%2C%20F.%20Krasniqi%2C%20U.%20Mey%2C%20et%20al.%20%26%23x201C%3BImpact%20of%20Individualized%20Treatment%20on%20Recovery%20from%20Fatigue%20and%20Return%20to%20Work%20in%20Survivors%20of%20Advanced-Stage%20Hodgkin%26%23x2019%3Bs%20Lymphoma%3A%20Results%20from%20the%20Randomized%20International%20GHSG%20HD18%20Trial.%26%23x201D%3B%20%26lt%3Bi%26gt%3BAnnals%20of%20Oncology%3A%20Official%20Journal%20of%20the%20European%20Society%20for%20Medical%20Oncology%26lt%3B%5C%2Fi%26gt%3B%2C%20December%205%2C%202023%2C%20S0923-7534%2823%2905102-5.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.annonc.2023.11.014%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.annonc.2023.11.014%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20individualized%20treatment%20on%20recovery%20from%20fatigue%20and%20return%20to%20work%20in%20survivors%20of%20advanced-stage%20Hodgkin%27s%20lymphoma%3A%20results%20from%20the%20randomized%20international%20GHSG%20HD18%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Ferdinandus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Damaschin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20S.%22%2C%22lastName%22%3A%22Jacob%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Meissner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Krasniqi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Mey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Sch%5Cu00f6ndube%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Thiemer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Mathas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Zijlstra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Greil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Feuring-Buske%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Markova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Kobe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.-T.%22%2C%22lastName%22%3A%22Eich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Baues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Fuchs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Borchmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Behringer%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Persisting%20cancer-related%20fatigue%20impairs%20health-related%20quality%20of%20life%20%28HRQoL%29%20and%20social%20reintegration%20in%20patients%20with%20Hodgkin%26%23039%3Bs%20lymphoma%20%28HL%29.%20The%20GHSG%20HD18%20trial%20established%20treatment%20de-escalation%20for%20advanced-stage%20HL%20guided%20by%20positron%20emission%20tomography%20after%20two%20cycles%20%28PET-2%29%20as%20new%20standard.%20Here%2C%20we%20investigate%20the%20impact%20of%20treatment%20de-escalation%20on%20long-term%20HRQoL%2C%20time%20to%20recovery%20from%20fatigue%20%28TTR-F%29%2C%20and%20time%20to%20return%20to%20work%20%28TTR-W%29.%5CnPATIENTS%20AND%20METHODS%3A%20Patients%20received%20European%20Organisation%20for%20Research%20and%20Treatment%20of%20Cancer%20Quality%20of%20Life%20Questionnaire%20C30%20%28EORTC%20QLQ-C30%29%20and%20life%20situation%20questionnaires%20at%20baseline%2C%20interim%2C%20end%20of%20treatment%2C%20and%20yearly%20follow-up.%20TTR-F%20was%20defined%20as%20time%20from%20the%20end%20of%20chemotherapy%20until%20the%20first%20fatigue%20score%20%26lt%3B30.%20TTR-W%20was%20analyzed%20in%20previously%20working%20or%20studying%20patients%20and%20measured%20from%20the%20end%20of%20treatment%20until%20the%20first%20documented%20work%20or%20education.%20We%20compared%20duration%20of%20treatment%20on%20TTR-F%20and%20TTR-W%20using%20Cox%20proportional%20hazards%20regression%20adjusted%20for%20confounding%20variables.%5CnRESULTS%3A%20HRQoL%20questionnaires%20at%20baseline%20were%20available%20in%201632%20%2883.9%25%29%20of%20all%20randomized%20patients.%20Overall%2C%20higher%20baseline%20fatigue%20and%20age%20were%20significantly%20associated%20with%20longer%20TTR-F%20and%20TTR-W%20and%20male%20sex%20with%20shorter%20TTR-W.%20Treatment%20reduction%20from%20eight%20to%20four%20chemotherapy%20cycles%20led%20to%20a%20significantly%20shorter%20TTR-F%20%5Bhazard%20ratio%20%28HR%29%201.41%2C%20P%5Cu00a0%3D%200.008%5D%20and%20descriptively%20shorter%20TTR-W%20%28HR%201.24%2C%20P%5Cu00a0%3D%200.084%29%20in%20PET-2-negative%20patients.%20Reduction%20from%20six%20to%20four%20cycles%20led%20to%20non-significant%20but%20plausible%20intermediate%20accelerations.%20The%20addition%20of%20rituximab%20caused%20significantly%20slower%20TTR-F%20%28HR%200.70%2C%20P%5Cu00a0%3D%200.0163%29%20and%20TTR-W%20%28HR%200.64%2C%20P%5Cu00a0%3D%200.0017%29%20in%20PET-2-positive%20patients.%20HRQoL%20at%20baseline%20and%20age%20were%20the%20main%20determinants%20of%202-year%20HRQoL.%5CnCONCLUSIONS%3A%20Individualized%20first-line%20treatment%20in%20patients%20with%20advanced-stage%20HL%20considerably%20shortens%20TTR-F%20and%20TTR-W%20in%20PET-2-negative%20patients.%20Our%20results%20support%20the%20use%20of%20response-adapted%20shortened%20treatment%20duration%20for%20patients%20with%20HL.%22%2C%22date%22%3A%222023-12-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.annonc.2023.11.014%22%2C%22ISSN%22%3A%221569-8041%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22W637CI9M%22%2C%22N24UXA6K%22%5D%2C%22dateModified%22%3A%222024-06-05T15%3A17%3A28Z%22%7D%7D%2C%7B%22key%22%3A%224VCSHCE8%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Scheibler%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-24%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BScheibler%2C%20F%26%23xFC%3Bl%26%23xF6%3Bp%2C%20Friedemann%20Geiger%2C%20Kai%20Wehkamp%2C%20Marion%20Danner%2C%20Marie%20Debrouwere%2C%20Constanze%20Stolz-Klingenberg%2C%20Anja%20Schuldt-Joswig%2C%20et%20al.%20%26%23x201C%3BPatient-Reported%20Effects%20of%20Hospital-Wide%20Implementation%20of%20Shared%20Decision-Making%20at%20a%20University%20Medical%20Centre%20in%20Germany%3A%20A%20Pre-Post%20Trial.%26%23x201D%3B%20%26lt%3Bi%26gt%3BBMJ%20Evidence-Based%20Medicine%26lt%3B%5C%2Fi%26gt%3B%2C%20November%2024%2C%202023%2C%20bmjebm-2023-112462.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjebm-2023-112462%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjebm-2023-112462%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Patient-reported%20effects%20of%20hospital-wide%20implementation%20of%20shared%20decision-making%20at%20a%20university%20medical%20centre%20in%20Germany%3A%20a%20pre-post%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%5Cu00fcl%5Cu00f6p%22%2C%22lastName%22%3A%22Scheibler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Geiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wehkamp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marion%22%2C%22lastName%22%3A%22Danner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Debrouwere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constanze%22%2C%22lastName%22%3A%22Stolz-Klingenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anja%22%2C%22lastName%22%3A%22Schuldt-Joswig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christina%20Gesine%22%2C%22lastName%22%3A%22Sommer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Kopeleva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22B%5Cu00fcnzen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Wagner-Ullrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerhard%22%2C%22lastName%22%3A%22Koch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Coors%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22Wehking%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marla%22%2C%22lastName%22%3A%22Clayman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Weymayr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonie%22%2C%22lastName%22%3A%22Sundmacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20To%20evaluate%20the%20feasibility%20and%20effectiveness%20of%20the%20SHARE%20TO%20CARE%20%28S2C%29%20programme%2C%20a%20complex%20intervention%20designed%20for%20hospital-wide%20implementation%20of%20shared%20decision-making%20%28SDM%29.%5CnDESIGN%3A%20Pre-post%20study.%5CnSETTING%3A%20University%20Hospital%20Schleswig-Holstein%20%28UKSH%29%2C%20Kiel%20Campus.%5CnPARTICIPANTS%3A%20Healthcare%20professionals%20as%20well%20as%20inpatients%20and%20outpatients%20from%2022%20departments%20of%20the%20Kiel%20Campus%20of%20UKSH.%5CnINTERVENTIONS%3A%20The%20S2C%20programme%20is%20a%20comprehensive%20implementation%20strategy%20including%20four%20core%20modules%3A%20%281%29%20physician%20training%2C%20%282%29%20SDM%20support%20training%20for%20and%20support%20by%20nurses%20as%20decision%20coaches%2C%20%283%29%20patient%20activation%20and%20%284%29%20evidence-based%20patient%20decision%20aid%20development%20and%20integration%20into%20patient%20pathways.%20After%20full%20implementation%2C%20departments%20received%20the%20S2C%20certificate.%5CnMAIN%20OUTCOME%20MEASURES%3A%20In%20this%20paper%2C%20we%20report%20on%20the%20feasibility%20and%20effectiveness%20outcomes%20of%20the%20implementation.%20Feasibility%20was%20judged%20by%20the%20degree%20of%20implementation%20of%20the%20four%20modules%20of%20the%20programme.%20Outcome%20measures%20for%20effectiveness%20are%20patient-reported%20experience%20measures%20%28PREMs%29.%20The%20primary%20outcome%20measure%20for%20effectiveness%20is%20the%20Patient%20Decision%20Making%20subscale%20of%20the%20Perceived%20Involvement%20in%20Care%20Scale%20%28PICSPDM%29.%20Pre-post%20comparisons%20were%20done%20using%20t-tests.%5CnRESULTS%3A%20The%20implementation%20of%20the%20four%20components%20of%20the%20S2C%20programme%20was%20able%20to%20be%20completed%20in%2018%20of%20the%2022%20included%20departments%20within%20the%20time%20frame%20of%20the%20study.%20After%20completion%20of%20implementation%2C%20PICSPDM%20showed%20a%20statistically%20significant%20difference%20%28p%26lt%3B0.01%29%20between%20the%20means%20compared%20with%20baseline.%20This%20difference%20corresponds%20to%20a%20small%20to%20medium%20yet%20clinically%20meaningful%20positive%20effect%20%28Hedges%26%23039%3B%20g%3D0.2%29.%20Consistent%20with%20this%2C%20the%20secondary%20PREMs%20%28Preparation%20for%20Decision%20Making%20and%20collaboRATE%29%20also%20showed%20statistically%20significant%2C%20clinically%20meaningful%20positive%20effects.%5CnCONCLUSIONS%3A%20The%20hospital-wide%20implementation%20of%20SDM%20with%20the%20S2C-programme%20proved%20to%20be%20feasible%20and%20effective%20within%20the%20time%20frame%20of%20the%20project.%20The%20German%20Federal%20Joint%20Committee%20has%20recommended%20to%20make%20the%20Kiel%20model%20of%20SDM%20a%20national%20standard%20of%20care.%22%2C%22date%22%3A%222023-11-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjebm-2023-112462%22%2C%22ISSN%22%3A%222515-4478%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%223L4EXKAR%22%2C%22Z33C2TVZ%22%2C%22J987ELTY%22%2C%22SPWXRLZV%22%2C%226DCTQ3Z4%22%2C%227ZDA33V6%22%2C%22QXIGN3AI%22%2C%22BEQ38XPW%22%2C%22P9CVNWVH%22%2C%22ERQ322N6%22%5D%2C%22dateModified%22%3A%222024-03-11T12%3A05%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22ZRVTGIJJ%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Biller-Andorno%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBiller-Andorno%2C%20Nikola%2C%20Martina%20Breuning%2C%20Anne%20Br%5Cu00fcning%2C%20Anna%20Geldermann%2C%20Andrea%20Gl%5Cu00e4ssel%2C%20Saskia%20J%5Cu00fcnger%2C%20Birgit%20Hiller%2C%20et%20al.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdngk.de%5C%2Fwp-content%5C%2Fuploads%5C%2F2023%5C%2F08%5C%2Fdngk-ag-eb-gute-praxiserfahrungsberichte2023-08-25.pdf%26%23039%3B%26gt%3BGute%20Praxis%20Erfahrungsberichte.%20Qualit%5Cu00e4tsanforderungen%20an%20Erfahrungsberichte%20im%20Gesundheitswesen.%20Positionspapier%20der%20AG%20Erfahrungsberichte%20im%20Gesundheitswesen%20im%20DNGK%20e.V.%26lt%3B%5C%2Fa%26gt%3B%26quot%3B%20DNGK-Positionspapiere.%20K%5Cu00f6ln%3A%20Deutsches%20Netzwerk%20Gesundheitskompetenz%20DNGK%2C%20July%2011%2C%202023.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22report%22%2C%22title%22%3A%22Gute%20Praxis%20Erfahrungsberichte.%20Qualit%5Cu00e4tsanforderungen%20an%20Erfahrungsberichte%20im%20Gesundheitswesen.%20Positionspapier%20der%20AG%20Erfahrungsberichte%20im%20Gesundheitswesen%20im%20DNGK%20e.V.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikola%22%2C%22lastName%22%3A%22Biller-Andorno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Breuning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Br%5Cu00fcning%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Geldermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Gl%5Cu00e4ssel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saskia%22%2C%22lastName%22%3A%22J%5Cu00fcnger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Birgit%22%2C%22lastName%22%3A%22Hiller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Holmberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klaus%22%2C%22lastName%22%3A%22Koch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans-G%5Cu00fcnter%22%2C%22lastName%22%3A%22Meyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%5Cu00fcnter%22%2C%22lastName%22%3A%22Ollenschl%5Cu00e4ger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvia%22%2C%22lastName%22%3A%22S%5Cu00e4nger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinna%22%2C%22lastName%22%3A%22Schaefer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Markus%22%2C%22lastName%22%3A%22Seelig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beate%22%2C%22lastName%22%3A%22Zschorlich%22%7D%2C%7B%22creatorType%22%3A%22seriesEditor%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22DNGK%20Deutsches%20Netzwerk%20Gesundheitskompetenz%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22reportNumber%22%3A%22%22%2C%22reportType%22%3A%22%22%2C%22institution%22%3A%22Deutsches%20Netzwerk%20Gesundheitskompetenz%20DNGK%22%2C%22date%22%3A%222023-07-11%22%2C%22language%22%3A%22de%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdngk.de%5C%2Fwp-content%5C%2Fuploads%5C%2F2023%5C%2F08%5C%2Fdngk-ag-eb-gute-praxiserfahrungsberichte2023-08-25.pdf%22%2C%22collections%22%3A%5B%22KT6HG7JE%22%2C%2246NNKHWR%22%2C%22LSGM8V2E%22%2C%22EBMCDUNP%22%2C%223PK7N8H4%22%2C%22PKCDUHK6%22%2C%22S2UTZ2YZ%22%2C%225UTTPGH2%22%2C%22J987ELTY%22%2C%22I6PUATQS%22%2C%225J4Z7MEL%22%2C%22BXIB6S4F%22%2C%22LIQP8YA3%22%2C%22ZEHT6V6W%22%2C%229J8DA2CX%22%2C%22RQEQARMJ%22%2C%22GL6YMRNG%22%2C%225W6EXM6X%22%5D%2C%22dateModified%22%3A%222024-05-15T09%3A13%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22FD4ZPS59%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Stolz-Klingenberg%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BStolz-Klingenberg%2C%20Constanze%2C%20Claudia%20B%26%23xFC%3Bnzen%2C%20Marie%20Coors%2C%20Charlotte%20Fl%26%23xFC%3Bh%2C%20Klarissa%20Hanja%20St%26%23xFC%3Brner%2C%20Kai%20Wehkamp%2C%20Marla%20L.%20Clayman%2C%20et%20al.%20%26%23x201C%3BComprehensive%20Implementation%20of%20Shared%20Decision%20Making%20in%20a%20Neuromedical%20Center%20Using%20the%20SHARE%20TO%20CARE%20Program.%26%23x201D%3B%20%26lt%3Bi%26gt%3BPatient%20Preference%20and%20Adherence%26lt%3B%5C%2Fi%26gt%3B%2017%20%282023%29%3A%20131%26%23x2013%3B39.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FPPA.S388432%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FPPA.S388432%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comprehensive%20Implementation%20of%20Shared%20Decision%20Making%20in%20a%20Neuromedical%20Center%20Using%20the%20SHARE%20TO%20CARE%20Program%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constanze%22%2C%22lastName%22%3A%22Stolz-Klingenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22B%5Cu00fcnzen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Coors%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Fl%5Cu00fch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klarissa%20Hanja%22%2C%22lastName%22%3A%22St%5Cu00fcrner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wehkamp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marla%20L.%22%2C%22lastName%22%3A%22Clayman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fueloep%22%2C%22lastName%22%3A%22Scheibler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wiebke%22%2C%22lastName%22%3A%22Sch%5Cu00fcttig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonie%22%2C%22lastName%22%3A%22Sundmacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Berg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Geiger%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20SHARE%20TO%20CARE%20%28S2C%29%20is%20a%20comprehensive%2C%20multi-module%20implementation%20program%20for%20shared%20decision%20making%20%28SDM%29.%20It%20is%20currently%20applied%20at%20the%20University%20Hospital%20Schleswig-Holstein%20in%20Kiel%2C%20Germany%2C%20and%20among%20general%20practitioners%20at%20the%20Federal%20State%20of%20Bremen.%20This%20study%20examines%20the%20results%20of%20the%20full%20implementation%20of%20S2C%20in%20terms%20of%20effectiveness%20within%20the%20Kiel%20Neuromedical%20Center%20comprising%20the%20departments%20of%20neurology%20and%20neurosurgery.%5CnMETHOD%20AND%20DESIGN%3A%20The%20S2C%20program%20consists%20of%20four%20combined%20intervention%20modules%3A%201%29%20multimodal%20training%20of%20physicians%3B%202%29%20a%20patient%20activation%20campaign%20including%20the%20ASK-3%20method%3B%203%29%20digital%20evidence-based%20patient%20decision%20aids%3B%20and%204%29%20SDM%20support%20by%20nurses%2C%20e.g.%2C%20as%20decision%20coaches.%20The%20SDM%20level%20before%20and%20immediately%20after%20implementation%20was%20retrospectively%20assessed%20in%20consecutively%20selected%20patients%20on%20the%20subscale%20%26quot%3BPatient%20Decision%20Making%26quot%3B%20of%20the%20Perceived%20Involvement%20in%20Care%20Scale%20%28PICSPDM%29.%20Mean%20scores%20were%20compared%20with%20t-tests.%5CnRESULTS%3A%20Eighty-nine%20percent%20of%20all%20physicians%20%28N%20%3D%2056%29%20completed%20the%20SDM%20training.%20We%20developed%20a%20total%20of%2012%20evidence-based%20digital%20decision%20aids%20in%20the%20center%2C%20educated%20two%20decision%20coaches%20to%20support%20patients%26%23039%3B%20decision%20processes%20by%20using%20decision%20aids.%20Physicians%20adjusted%20patients%26%23039%3B%20pathways%20to%20incorporate%20the%20use%20of%20decision%20aids.%20Patients%20%28n%20%3D%20261%29%20reported%20a%20significant%20increase%20in%20participation%20%28p%26lt%3B0.001%3B%20Hedges%26%23039%3B%20g%20%3D%200.49%29%20in%20medical%20decision%20making.%5CnCONCLUSION%3A%20The%20S2C%20program%20has%20been%20successfully%20implemented%20within%20the%20entire%20Neuromedical%20Center.%20Patients%20reported%20a%20medium%20to%20small%20increase%20of%20perceived%20involvement%20in%20decision%20making%20demonstrating%20the%20effectiveness%20of%20the%20implementation.%20For%20future%20research%2C%20it%20might%20be%20interesting%20to%20investigate%20the%20sustainability%20of%20the%20effects%20of%20S2C.%20In%20addition%2C%20it%20seems%20useful%20to%20complement%20the%20patient-based%20evaluation%20with%20observer-based%20data.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2147%5C%2FPPA.S388432%22%2C%22ISSN%22%3A%221177-889X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZFT52UPQ%22%2C%2246NNKHWR%22%2C%222G8YLGV7%22%2C%223L4EXKAR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22SPWXRLZV%22%2C%226DCTQ3Z4%22%2C%22ZKMQLZWF%22%2C%22QXIGN3AI%22%2C%22P9CVNWVH%22%5D%2C%22dateModified%22%3A%222024-05-27T14%3A26%3A42Z%22%7D%7D%2C%7B%22key%22%3A%2229935MWJ%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Danner%20et%20al.%22%2C%22parsedDate%22%3A%222022-02-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDanner%2C%20Marion%2C%20Marie%20Debrouwere%2C%20Anne%20Rummer%2C%20Kai%20Wehkamp%2C%20Jens%20Ulrich%20R%5Cu00fcffer%2C%20Friedemann%20Geiger%2C%20Robert%20Wolff%2C%20Karoline%20Weik%2C%20and%20Fueloep%20Scheibler.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12911-022-01777-x%26%23039%3B%26gt%3BA%20scattered%20landscape%3A%20assessment%20of%20the%20evidence%20base%20for%2071%20patient%20decision%20aids%20developed%20in%20a%20hospital%20setting%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BBMC%20Medical%20Informatics%20and%20Decision%20Making%26lt%3B%5C%2Fi%26gt%3B%2022%2C%20no.%201%20%28February%2017%2C%202022%29%3A%2044.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20scattered%20landscape%3A%20assessment%20of%20the%20evidence%20base%20for%2071%20patient%20decision%20aids%20developed%20in%20a%20hospital%20setting%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marion%22%2C%22lastName%22%3A%22Danner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Debrouwere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Rummer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wehkamp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Geiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Wolff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karoline%22%2C%22lastName%22%3A%22Weik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fueloep%22%2C%22lastName%22%3A%22Scheibler%22%7D%5D%2C%22abstractNote%22%3A%22Recent%20publications%20reveal%20shortcomings%20in%20evidence%20review%20and%20summarization%20methods%20for%20patient%20decision%20aids.%20In%20the%20large-scale%20%5Cu201cShare%20to%20Care%20%28S2C%29%5Cu201d%20Shared%20Decision%20Making%20%28SDM%29%20project%20at%20the%20University%20Hospital%20Kiel%2C%20Germany%2C%20one%20of%204%20SDM%20interventions%20was%20to%20develop%20up%20to%2080%20decision%20aids%20for%20patients.%20Best%20available%20evidence%20on%20the%20treatments%5Cu2019%20impact%20on%20patient-relevant%20outcomes%20was%20systematically%20appraised%20to%20feed%20this%20information%20into%20the%20decision%20aids.%20Aims%20of%20this%20paper%20were%20to%20%281%29%20describe%20how%20PtDAs%20are%20developed%20and%20how%20S2C%20evidence%20reviews%20for%20each%20PtDA%20are%20conducted%2C%20%282%29%20appraise%20the%20quality%20of%20the%20best%20available%20evidence%20identified%20and%20%283%29%20identify%20challenges%20associated%20with%20identified%20evidence.%22%2C%22date%22%3A%222022-02-17%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12911-022-01777-x%22%2C%22ISSN%22%3A%221472-6947%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12911-022-01777-x%22%2C%22collections%22%3A%5B%22ZFT52UPQ%22%2C%2246NNKHWR%22%2C%223L4EXKAR%22%2C%22J987ELTY%22%2C%22DCC2W2YR%22%2C%227ZDA33V6%22%2C%22P9CVNWVH%22%2C%22N24UXA6K%22%5D%2C%22dateModified%22%3A%222024-06-05T08%3A50%3A37Z%22%7D%7D%2C%7B%22key%22%3A%227HPFIN8W%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Stolz-Klingenberg%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BStolz-Klingenberg%2C%20Constanze%2C%20Claudia%20B%5Cu00fcnzen%2C%20Marie%20Coors%2C%20Charlotte%20Fl%5Cu00fch%2C%20Nils%20G.%20Margraf%2C%20Kai%20Wehkamp%2C%20Marla%20L.%20Clayman%2C%20et%20al.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticles%5C%2F10.3389%5C%2Ffneur.2022.1037447%26%23039%3B%26gt%3BSustainability%20of%20large-scale%20implementation%20of%20shared%20decision%20making%20with%20the%20SHARE%20TO%20CARE%20program%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BFrontiers%20in%20Neurology%26lt%3B%5C%2Fi%26gt%3B%2013%20%282022%29.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sustainability%20of%20large-scale%20implementation%20of%20shared%20decision%20making%20with%20the%20SHARE%20TO%20CARE%20program%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Constanze%22%2C%22lastName%22%3A%22Stolz-Klingenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22B%5Cu00fcnzen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Coors%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Fl%5Cu00fch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nils%20G.%22%2C%22lastName%22%3A%22Margraf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wehkamp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marla%20L.%22%2C%22lastName%22%3A%22Clayman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fueloep%22%2C%22lastName%22%3A%22Scheibler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22Wehking%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wiebke%22%2C%22lastName%22%3A%22Sch%5Cu00fcttig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonie%22%2C%22lastName%22%3A%22Sundmacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Synowitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Berg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Geiger%22%7D%5D%2C%22abstractNote%22%3A%22IntroductionSHARE%20TO%20CARE%20%28S2C%29%20is%20a%20comprehensive%20implementation%20program%20for%20shared%20decision%20making%20%28SDM%29.%20It%20is%20run%20at%20the%20University%20Hospital%20Schleswig-Holstein%20%28UKSH%29%20in%20Kiel%2C%20Germany%2C%20and%20consists%20of%20four%20combined%20intervention%20modules%20addressing%20healthcare%20professionals%20and%20patients%3A%20%281%29%20multimodal%20training%20of%20physicians%20%282%29%20patient%20activation%20campaign%20including%20the%20ASK3%20method%2C%20%283%29%20online%20evidence-based%20patient%20decision%20aids%20%284%29%20SDM%20support%20by%20nurses.%20This%20study%20examines%20the%20sustainability%20of%20the%20hospital%20wide%20SDM%20implementation%20by%20means%20of%20the%20Neuromedical%20Center%20comprising%20the%20Departments%20of%20Neurology%20and%20Neurosurgery.MethodsBetween%202018%20and%202020%2C%20the%20S2C%20program%20was%20applied%20initially%20within%20the%20Neuromedical%20Center%3A%20We%20implemented%20the%20patient%20activation%20campaign%2C%20trained%2089%25%20of%20physicians%20%28N%20%3D%2056%29%2C%20developed%2012%20patient%20decision%20aids%20and%20educated%20two%20decision%20coaches.%20Physicians%20adjusted%20the%20patients%26%23039%3B%20pathways%20to%20facilitate%20the%20use%20of%20decision%20aids.%20To%20maintain%20the%20initial%20implementation%2C%20the%20departments%20took%20care%20that%20new%20staff%20members%20received%20training%20and%20decision%20aids%20were%20updated.%20The%20patient%20activation%20campaign%20was%20continued.%20To%20determine%20the%20sustainability%20of%20the%20initial%20intervention%2C%20the%20SDM%20level%20after%20a%20maintenance%20phase%20of%206%5Cu201318%20months%20was%20compared%20to%20the%20baseline%20level%20before%20implementation.%20Therefore%2C%20in-%20and%20outpatients%20received%20a%20questionnaire%20via%20mail%20after%20discharge.%20The%20primary%20endpoint%20was%20the%20%5Cu201cPatient%20Decision%20Making%5Cu201d%20subscale%20of%20the%20Perceived%20Involvement%20in%20Care%20Scale%20%28PICSPDM%29.%20Secondary%20endpoints%20were%20an%20additional%20scale%20measuring%20SDM%20%28CollaboRATE%29%2C%20and%20the%20PrepDM%20scale%2C%20which%20determines%20patients%26%23039%3B%20perceived%20health%20literacy%20while%20preparing%20for%20decision%20making.%20Mean%20scale%20scores%20were%20compared%20using%20t-tests.ResultsPatients%20reported%20a%20significantly%20increased%20SDM%20level%20%28PICSPDMp%20%3D%200.02%3B%20Hedges%26%23039%3B%20g%20%3D%200.33%3B%20CollaboRATE%20p%20%3D%200.05%3B%20Hedges%26%23039%3B%20g%20%3D%200.26%29%20and%20improved%20preparation%20for%20decision%20making%20%28PrepDM%20p%20%3D%200.001%3B%20Hedges%26%23039%3B%20g%20%3D%200.34%29%206%5Cu201318%20months%20after%20initial%20implementation%20of%20S2C.DiscussionThe%20S2C%20program%20demonstrated%20its%20sustainability%20within%20the%20Neuromedical%20Center%20at%20UKSH%20Kiel%20in%20terms%20of%20increased%20SDM%20and%20health%20literacy.%20Maintaining%20the%20SDM%20implementation%20required%20a%20fraction%20of%20the%20initial%20intensity.%20The%20departments%20took%20on%20the%20responsibility%20for%20maintenance.%20Meanwhile%2C%20an%20additional%20health%20insurance-based%20reimbursement%20for%20S2C%20secures%20the%20continued%20application%20of%20the%20program.ConclusionSHARE%20TO%20CARE%20promises%20to%20be%20suitable%20for%20long-lasting%20implementation%20of%20SDM%20in%20hospitals.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221664-2295%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticles%5C%2F10.3389%5C%2Ffneur.2022.1037447%22%2C%22collections%22%3A%5B%22ZFT52UPQ%22%2C%2246NNKHWR%22%2C%223L4EXKAR%22%2C%22J987ELTY%22%2C%22SPWXRLZV%22%2C%226DCTQ3Z4%22%2C%22ZKMQLZWF%22%2C%22QXIGN3AI%22%2C%22P9CVNWVH%22%2C%22ERQ322N6%22%2C%22WK7W2JLX%22%5D%2C%22dateModified%22%3A%222024-05-26T15%3A46%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22FXFQSNG8%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fischer%20et%20al.%22%2C%22parsedDate%22%3A%222021-10-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFischer%2C%20Irene%2C%20Jens%20Ulrich%20R%5Cu00fcffer%2C%20and%20Manfred%20E.%20Heim.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC8491440%5C%2F%26%23039%3B%26gt%3BTumorassoziierte%20Fatigue%20bei%20Immuncheckpointinhibitoren%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BDer%20Onkologe%26lt%3B%5C%2Fi%26gt%3B%2C%20October%205%2C%202021%2C%201%5Cu20135.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00761-021-01042-2.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tumorassoziierte%20Fatigue%20bei%20Immuncheckpointinhibitoren%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irene%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manfred%20E.%22%2C%22lastName%22%3A%22Heim%22%7D%5D%2C%22abstractNote%22%3A%22Tumorassoziierte%20Fatigue%20%28%5Cu201ecancer-related%20fatigue%5Cu201c%2C%20CRF%29%20ist%20ein%20von%20vielen%20Krebspatienten%20berichteter%2C%20belastender%20und%20beeintr%5Cu00e4chtigender%20Zustand%20von%20atypischer%20M%5Cu00fcdigkeit%2C%20Ersch%5Cu00f6pfung%20und%20Energiemangel.%20Die%20Genese%20ist%20meist%20multikausal%2C%20wobei%20somatische%2C%20psychische%2C%20kognitive%20und%20psychosoziale%20Faktoren%20zusammenwirken%20und%20zu%20der%20gemeinsamen%20Endstrecke%20CRF%20f%5Cu00fchren.%20CRF%20kommt%20auch%20im%20Zusammenhang%20mit%20Immuncheckpointinhibitoren%20%28ICI%29%20vor.%20Da%20die%20Toxizit%5Cu00e4t%20der%20ICI%20aber%20nicht%20immer%20die%20einzige%20Ursache%20ist%2C%20sollten%20diagnostisch%20immer%20auch%20weitere%20Ursachen%20und%20Einflussfaktoren%20eruiert%20werden%2C%20um%20diese%20%28evidenzbasiert%29%20behandeln%20zu%20k%5Cu00f6nnen.%20Zudem%20sollten%20die%20Patienten%20%28auch%20pr%5Cu00e4ventiv%29%20beruhigend%20%5Cu00fcber%20CRF%20aufgekl%5Cu00e4rt%20und%20zu%20Gegenma%5Cu00dfnahmen%20beraten%20werden.%20Vorurteilsfreies%20Zuh%5Cu00f6ren%20und%20die%20Bereitschaft%2C%20mit%20dem%20Patienten%20gemeinsam%20aus%20dem%20Spektrum%20der%20f%5Cu00fcr%20ihn%20sinnvollen%20Interventionen%20diejenigen%20auszuw%5Cu00e4hlen%2C%20die%20zu%20ihm%20und%20zu%20seinen%20Lebensumst%5Cu00e4nden%20passen%20und%20die%20von%20ihm%20realisiert%20werden%20k%5Cu00f6nnen%2C%20sind%20bereits%20sehr%20wirksam.%22%2C%22date%22%3A%222021-10-5%22%2C%22language%22%3A%22de%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00761-021-01042-2%22%2C%22ISSN%22%3A%220947-8965%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC8491440%5C%2F%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-03-13T08%3A53%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22A4GMMTLZ%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22W%5Cu00fcnsch%20et%20al.%22%2C%22parsedDate%22%3A%222021-10-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BW%5Cu00fcnsch%2C%20Alexander%2C%20Corinna%20Bergelt%2C%20Heide%20G%5Cu00f6tze%2C%20Andr%5Cu00e9%20Karger%2C%20Karin%20Oechsle%2C%20Jens%20Ulrich%20R%5Cu00fcffer%2C%20Dorothee%20Speiser%2C%20and%20Frank%20Vitinius.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12312-021-00972-7%26%23039%3B%26gt%3BKommunikationstrainings%20f%5Cu00fcr%20onkologisch%20t%5Cu00e4tige%20%5Cu00c4rzt%2Ainnen%20in%20Deutschland%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BForum%26lt%3B%5C%2Fi%26gt%3B%2036%2C%20no.%205%20%28October%201%2C%202021%29%3A%20391%5Cu201395.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Kommunikationstrainings%20f%5Cu00fcr%20onkologisch%20t%5Cu00e4tige%20%5Cu00c4rzt%2Ainnen%20in%20Deutschland%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22W%5Cu00fcnsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinna%22%2C%22lastName%22%3A%22Bergelt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heide%22%2C%22lastName%22%3A%22G%5Cu00f6tze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9%22%2C%22lastName%22%3A%22Karger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karin%22%2C%22lastName%22%3A%22Oechsle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dorothee%22%2C%22lastName%22%3A%22Speiser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Vitinius%22%7D%5D%2C%22abstractNote%22%3A%22Der%20Nationale%20Krebsplan%20%28NKP%29%20und%20die%20S3-Leitlinie%20zur%20Psychoonkologie%20sehen%20vor%2C%20dass%20alle%20in%20der%20Onkologie%20T%5Cu00e4tigen%20%5Cu00fcber%20kommunikative%20Kompetenzen%20verf%5Cu00fcgen%20sollten.%20%5Cu00dcber%20gezieltes%20Kommunikationstraining%20k%5Cu00f6nnen%20diese%20Kompetenzen%20erworben%20werden%2C%20was%20in%20Metanalysen%20mehrfach%20gezeigt%20wurde.%20In%20diesem%20Beitrag%20werden%20einige%20ausgew%5Cu00e4hlte%20Kommunikationstrainings%20in%20Deutschland%20vorgestellt%20und%20anhand%20der%20Empfehlungen%20des%20NKP%20oder%20von%20Kriterien%2C%20die%20Experten%20aufgestellt%20haben%2C%20beschrieben.%20Es%20existiert%20eine%20Reihe%20teilmanualisierter%20Kommunikationstrainings%2C%20die%20sich%20im%20Rahmen%20von%20Forschungsprojekten%20als%20gut%20umsetzbar%20erwiesen%20haben.%20Einzelne%20Standorte%20haben%20ein%20Trainingsprogramm%20routinem%5Cu00e4%5Cu00dfig%20implementiert.%20Eine%20regelhafte%20Implementierung%2C%20in%20der%20alle%20onkologisch%20T%5Cu00e4tigen%20geschult%20werden%2C%20wird%20jedoch%20bisher%20von%20keinem%20Projekt%20erreicht.%22%2C%22date%22%3A%222021-10-01%22%2C%22language%22%3A%22de%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12312-021-00972-7%22%2C%22ISSN%22%3A%222190-9784%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12312-021-00972-7%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22SPWXRLZV%22%2C%22W637CI9M%22%2C%22P9CVNWVH%22%5D%2C%22dateModified%22%3A%222025-05-18T07%3A50%3A54Z%22%7D%7D%2C%7B%22key%22%3A%226VT2X3GI%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22M%5Cu00fcller%20et%20al.%22%2C%22parsedDate%22%3A%222021-07-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BM%26%23xFC%3Bller%2C%20Karolina%2C%20Jens%20G.%20Kuipers%2C%20Joachim%20Weis%2C%20Irene%20Fischer%2C%20Tobias%20Pukrop%2C%20Jens%20U.%20R%26%23xFC%3Bffer%2C%20and%20Michael%20Koller.%20%26%23x201C%3BSelf-Reported%20Fatigue%20in%20Patients%20with%20Rheumatoid%20Arthritis%20Compared%20to%20Patients%20with%20Cancer%3A%20Results%20from%20Two%20Large-Scale%20Studies.%26%23x201D%3B%20%26lt%3Bi%26gt%3BRheumatology%20International%26lt%3B%5C%2Fi%26gt%3B%2C%20July%2016%2C%202021.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00296-021-04948-7%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00296-021-04948-7%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Self-reported%20fatigue%20in%20patients%20with%20rheumatoid%20arthritis%20compared%20to%20patients%20with%20cancer%3A%20results%20from%20two%20large-scale%20studies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karolina%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20G.%22%2C%22lastName%22%3A%22Kuipers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joachim%22%2C%22lastName%22%3A%22Weis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irene%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tobias%22%2C%22lastName%22%3A%22Pukrop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Koller%22%7D%5D%2C%22abstractNote%22%3A%22Fatigue%20is%20a%20common%20symptom%20in%20patients%20with%20rheumatoid%20arthritis%20%28RA%29%20and%20in%20patients%20with%20cancer%20%28CA%29.%20The%20aim%20was%20to%20investigate%20the%20degree%20of%20fatigue%20in%20RA%20patients%20as%20compared%20to%20CA%20patients%20as%20well%20as%20potential%20influencing%20factors%20on%20RA-related%20fatigue.%20This%20was%20a%20retrospective%20analyses%20of%20two%20prospective%20cohort%20studies%20that%20used%20the%20EORTC%20QLQ-FA12%20as%20a%20common%20instrument%20to%20assess%20fatigue.%20The%20cohort%20of%20RA%20patients%20was%20based%20on%20a%20nationwide%20survey%20in%20Germany.%20The%20cohort%20of%20CA%20patients%20was%20recruited%20in%20the%20context%20of%20an%20international%20validation%20field%20study.%20Multivariable%20ANCOVAs%20compared%20levels%20of%20fatigue%20between%20the%20two%20cohorts%2C%20also%20including%20various%20subgroup%20analyses.%20Regression%20analyses%20explored%20influencing%20factors%20on%20RA%20patients%26%23039%3B%20fatigue.%20Data%20of%20n%5Cu2009%3D%5Cu2009705%20RA%20patients%20and%20of%20n%5Cu2009%3D%5Cu2009943%20CA%20patients%20were%20available%20for%20analyses.%20RA%20patients%20reported%20significantly%20higher%20Physical%20Fatigue%20%28mean%20difference%5Cu2009%3D%5Cu20097.0%2C%2095%25%20CI%5Cu20094.2-9.7%2C%20p%5Cu2009%26lt%3B%5Cu20090.001%29%20and%20Social%20Sequelae%20%28mean%20difference%5Cu2009%3D%5Cu20097.5%2C%2095%25%20CI%5Cu20094.7-10.2%2C%20p%5Cu2009%26lt%3B%5Cu20090.001%29.%20CA%20patients%20reported%20higher%20Cognitive%20Fatigue%20%28mean%20difference%5Cu2009%3D%5Cu20093.5%2C%2095%25%20CI%5Cu20091.4-5.6%2C%20p%5Cu2009%3D%5Cu20090.001%29.%20No%20differences%20in%20Emotional%20Fatigue%20%28p%5Cu2009%3D%5Cu20090.678%29%20and%20Interference%20with%20Daily%20Life%20%28p%5Cu2009%3D%5Cu20090.098%29%20were%20found.%20In%20RA%20patients%2C%20mental%20health%20and%20pain%20were%20associated%20with%20fatigue%20%28p%20values%5Cu2009%26lt%3B%5Cu20090.001%29.%20RA%20patients%20showed%20a%20considerable%20level%20of%20fatigue%20that%20is%20comparable%20to%20and%20in%20certain%20cases%20even%20higher%20than%20that%20of%20CA%20patients.%20The%20implementation%20of%20standardized%20diagnostic%20procedures%20and%20interventions%20to%20reduce%20fatigue%20in%20RA%20patients%20are%20recommended.%22%2C%22date%22%3A%222021-07-16%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00296-021-04948-7%22%2C%22ISSN%22%3A%221437-160X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A29%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22PB6BZ4L2%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wehkamp%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-14%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWehkamp%2C%20Kai%2C%20Felicia%20Beatrice%20Kiefer%2C%20Friedemann%20Geiger%2C%20Fueloep%20Scheibler%2C%20Jens%20Ulrich%20Rueffer%2C%20Norbert%20Donner-Banzhoff%2C%20and%20Cornelia%20Betsch.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.dovepress.com%5C%2Fenhancing-specific-health-literacy-with-a-digital-evidence-based-patie-peer-reviewed-fulltext-article-PPA%26%23039%3B%26gt%3BEnhancing%20Specific%20Health%20Literacy%20with%20a%20Digital%20Evidence-Based%20Patient%20Decision%20Aid%20for%20Hypertension%3A%20A%20Randomized%20Controlled%20Trial.%26lt%3B%5C%2Fa%26gt%3B%26quot%3B%20%26lt%3Bi%26gt%3BPatient%20Preference%20and%20Adherence%26lt%3B%5C%2Fi%26gt%3B%2015%20%28June%2014%2C%202021%29%3A%201269%5Cu201379.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FPPA.S311470.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Enhancing%20Specific%20Health%20Literacy%20with%20a%20Digital%20Evidence-Based%20Patient%20Decision%20Aid%20for%20Hypertension%3A%20A%20Randomized%20Controlled%20Trial.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wehkamp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felicia%20Beatrice%22%2C%22lastName%22%3A%22Kiefer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Geiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fueloep%22%2C%22lastName%22%3A%22Scheibler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22Rueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Norbert%22%2C%22lastName%22%3A%22Donner-Banzhoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cornelia%22%2C%22lastName%22%3A%22Betsch%22%7D%5D%2C%22abstractNote%22%3A%22Enhancing%20Specific%20Health%20Literacy%20with%20a%20Digital%20Evidence-Based%20Patient%20Decision%20Aid%20for%20Hypertension%20%5Cu2013%20a%20Randomized%20Controlled%20Trial%22%2C%22date%22%3A%222021%5C%2F06%5C%2F14%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.2147%5C%2FPPA.S311470%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.dovepress.com%5C%2Fenhancing-specific-health-literacy-with-a-digital-evidence-based-patie-peer-reviewed-fulltext-article-PPA%22%2C%22collections%22%3A%5B%22ZFT52UPQ%22%2C%2246NNKHWR%22%2C%222G8YLGV7%22%2C%223L4EXKAR%22%2C%22R2J5Y2I9%22%2C%22J987ELTY%22%2C%227C3HQD4E%22%2C%22ERQ322N6%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A58%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22XC9Q3DJ2%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Debrouwere%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDebrouwere%2C%20Marie%2C%20Anne%20Rummer%2C%20Divna%20Tafelski%2C%20Corinna%20Knauff%2C%20Friedemann%20Geiger%2C%20Kai%20Wehkamp%2C%20Ulrich%20R%26%23xFC%3Bffer%2C%20F%26%23xFC%3Bl%26%23xF6%3Bp%20Scheibler%2C%20and%20Marion%20Danner.%20%26%23x201C%3BWie%20gut%20ist%20die%20Studienlage%20f%26%23xFC%3Br%20wichtige%20Behandlungsentscheidungen%20im%20Krankenhaus%3F%2C%26%23x201D%3B%20Doc21ebmPS-4%26%23x2013%3B10.%20German%20Medical%20Science%20GMS%20Publishing%20House%2C%202021.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3205%5C%2F21ebm081%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3205%5C%2F21ebm081%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22conferencePaper%22%2C%22title%22%3A%22Wie%20gut%20ist%20die%20Studienlage%20f%5Cu00fcr%20wichtige%20Behandlungsentscheidungen%20im%20Krankenhaus%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Debrouwere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Rummer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Divna%22%2C%22lastName%22%3A%22Tafelski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinna%22%2C%22lastName%22%3A%22Knauff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Geiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wehkamp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%5Cu00fcl%5Cu00f6p%22%2C%22lastName%22%3A%22Scheibler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marion%22%2C%22lastName%22%3A%22Danner%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222021-02-23%22%2C%22proceedingsTitle%22%3A%22%22%2C%22conferenceName%22%3A%22%22%2C%22language%22%3A%22germ%22%2C%22DOI%22%3A%2210.3205%5C%2F21ebm081%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%223L4EXKAR%22%2C%22J987ELTY%22%2C%22SPWXRLZV%22%2C%22DCC2W2YR%22%2C%227ZDA33V6%22%2C%22QXIGN3AI%22%2C%22BEQ38XPW%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A55%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22KEF4KIKZ%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Geiger%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGeiger%2C%20Friedemann%2C%20Anna%20Novelli%2C%20Daniela%20Berg%2C%20Claudia%20Hacke%2C%20Leonie%20Sundmacher%2C%20Olga%20Kopeleva%2C%20F%5Cu00fcl%5Cu00f6p%20Scheibler%2C%20Jens%20Ulrich%20R%5Cu00fcffer%2C%20Christine%20Kuch%2C%20and%20Kai%20Wehkamp.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.aerzteblatt.de%5C%2Fpdf.asp%3Fid%3D218776%26%23039%3B%26gt%3BKlinikweite%20Implementierung%20von%20Shared%20Decision%20Making.%20Erste%20Ergebnisse%20des%20Kieler%20Innovationsprojekts%20zum%20SHARE%20TO%20CARE%20Programm.%26lt%3B%5C%2Fa%26gt%3B%26quot%3B%20%26lt%3Bi%26gt%3BDtsch%20%5Cu00c4rzteblatt%26lt%3B%5C%2Fi%26gt%3B%20118%2C%20no.%2013%20%28February%204%2C%202021%29%3A%20225%5Cu201326.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3238%5C%2Faerztebl.m2021.0144.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Klinikweite%20Implementierung%20von%20Shared%20Decision%20Making.%20Erste%20Ergebnisse%20des%20Kieler%20Innovationsprojekts%20zum%20SHARE%20TO%20CARE%20Programm.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Geiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Novelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Berg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Hacke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonie%22%2C%22lastName%22%3A%22Sundmacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Kopeleva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%5Cu00fcl%5Cu00f6p%22%2C%22lastName%22%3A%22Scheibler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Kuch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wehkamp%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2202.04.2021%22%2C%22language%22%3A%22DE%22%2C%22DOI%22%3A%2210.3238%5C%2Faerztebl.m2021.0144%22%2C%22ISSN%22%3A%220172-2107%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.aerzteblatt.de%5C%2Fpdf.asp%3Fid%3D218776%22%2C%22collections%22%3A%5B%22ZFT52UPQ%22%2C%2246NNKHWR%22%2C%223L4EXKAR%22%2C%22J987ELTY%22%2C%227C3HQD4E%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A57%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22TUGBL9E7%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gebauer%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGebauer%2C%20Judith%2C%20Jens%20U.%20R%5Cu00fcffer%2C%20and%20Georg%20Brabant.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-3-030-49140-6_17%26%23039%3B%26gt%3BCancer-Related%20Fatigue%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20In%20%26lt%3Bi%26gt%3BLate%20Treatment%20Effects%20and%20Cancer%20Survivor%20Care%20in%20the%20Young%3A%20From%20Childhood%20to%20Early%20Adulthood%26lt%3B%5C%2Fi%26gt%3B%2C%20edited%20by%20J%5Cu00f6rn%20D.%20Beck%2C%20Carsten%20Bokemeyer%2C%20and%20Thorsten%20Langer%2C%20157%5Cu201365.%20Cham%3A%20Springer%20International%20Publishing%2C%202021.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Cancer-Related%20Fatigue%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Gebauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georg%22%2C%22lastName%22%3A%22Brabant%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22J%5Cu00f6rn%20D.%22%2C%22lastName%22%3A%22Beck%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Carsten%22%2C%22lastName%22%3A%22Bokemeyer%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Thorsten%22%2C%22lastName%22%3A%22Langer%22%7D%5D%2C%22abstractNote%22%3A%22Cancer-related%20fatigue%20%28CrF%29%20is%20a%20common%20condition%20affecting%20up%20to%2040%25%20of%20cancer%20patients.%20It%20is%20characterized%20by%20a%20persistent%20or%20relapsing%20exhaustion%20that%20lasts%20for%20more%20than%206%20months%20and%20does%20not%20improve%20with%20sleep%20or%20rest.%20CrF%20can%20be%20classified%20in%20mild%2C%20moderate%20or%20severe%2C%20depending%20on%20the%20degree%20of%20impairment.%20Although%20improvement%20is%20possible%2C%20many%20patients%20suffer%20from%20long-term%20illness%20and%20disability%20that%20significantly%20impair%20quality%20of%20life.%20Multiple%20factors%20may%20contribute%20to%20the%20development%20of%20CrF%20including%20cancer%20itself%2C%20cancer%20treatment%2C%20comorbidities%20and%20medications%20as%20well%20as%20genetic%20factors.%20The%20diagnosis%20of%20CrF%20is%20based%20on%20a%20detailed%20medical%20history%20and%20should%20be%20supported%20by%20specific%20questionnaires%20for%20the%20assessment%20of%20the%20extent%20of%20fatigue.%20Treatable%20contributing%20factors%20%28e.g.%20cardiac%2C%20renal%2C%20pulmonary%20or%20endocrine%20dysfunctions%20as%20well%20as%20anaemia%2C%20arthritis%20or%20neuromuscular%20diseases%29%20should%20be%20excluded.%20Treatment%20for%20CrF%20aims%20to%20reduce%20the%20symptoms%20and%20includes%20physical%20exercises%2C%20psychosocial%20interventions%20%28behavioural%20and%5C%2For%20%28psycho%29educational%20therapy%29%20and%20complemental%20interventions.%20The%20role%20of%20pharmacologic%20interventions%20in%20the%20therapy%20of%20CrF%20still%20needs%20to%20be%20evaluated.%20Although%20CrF%20may%20persist%20after%20cancer%20treatment%2C%20full%20recovery%20is%20possible%20and%20has%20been%20demonstrated%20particularly%20in%20children%20and%20young%20adults.%22%2C%22bookTitle%22%3A%22Late%20Treatment%20Effects%20and%20Cancer%20Survivor%20Care%20in%20the%20Young%3A%20From%20Childhood%20to%20Early%20Adulthood%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22en%22%2C%22ISBN%22%3A%22978-3-030-49140-6%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-3-030-49140-6_17%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A29%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22KDIBKFGV%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Geiger%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGeiger%2C%20Friedemann%2C%20Claudia%20Hacke%2C%20Judith%20Potthoff%2C%20Fueloep%20Scheibler%2C%20Jens%20Ulrich%20Rueffer%2C%20Christine%20Kuch%2C%20and%20Kai%20Wehkamp.%20%26%23x201C%3BThe%20Effect%20of%20a%20Scalable%20Online%20Training%20Module%20for%20Shared%20Decision%20Making%20Based%20on%20Flawed%20Video%20Examples%20-%20a%20Randomized%20Controlled%20Trial.%26%23x201D%3B%20%26lt%3Bi%26gt%3BPatient%20Education%20and%20Counseling%26lt%3B%5C%2Fi%26gt%3B%2C%20November%2027%2C%202020.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.pec.2020.11.033%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.pec.2020.11.033%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20effect%20of%20a%20scalable%20online%20training%20module%20for%20shared%20decision%20making%20based%20on%20flawed%20video%20examples%20-%20a%20randomized%20controlled%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Geiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Hacke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Potthoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fueloep%22%2C%22lastName%22%3A%22Scheibler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22Rueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Kuch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wehkamp%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Shared%20Decision%20Making%20%28SDM%29%20is%20considered%20the%20gold%20standard%20of%20medical%20decision%20making%20as%20it%20provides%20a%20method%20to%20systematically%20integrate%20the%20patient%26%23039%3Bs%20preferences%2C%20evidence-based%20medicine%20and%20the%20experience%20of%20health%20care%20professionals.%20Therefore%2C%20evidence-based%20training%20methods%20for%20a%20broad%20implementation%20into%20healthcare%20are%20needed.%20A%20new%20online%20training%20was%20designed%2C%20based%20on%20the%20concept%20of%20flawed%5C%2Fflawless%20video%20examples%20and%20additional%20educational%20concepts.%5CnMETHODS%3A%20In%20a%20single-blind%20randomized-controlled%20trial%2C%20medical%20students%20were%20randomly%20assigned%20to%20intervention%20group%20receiving%20the%20online%20training%20%28n%20%3D%2082%29%20or%20waiting%20control%20group%20%28n%20%3D%20105%29.%20SDM-related%20knowledge%20and%20the%20ability%20to%20judge%20distinct%20levels%20of%20SDM%20were%20compared%20between%20both%20groups.%20Additionally%2C%20feedback%20regarding%20the%20intervention%20was%20collected.%5CnRESULTS%3A%20SDM-related%20knowledge%20and%20judging%20ability%20increased%20significantly%20in%20the%20intervention%20group%20compared%20to%20controls%20%28SDM%20knowledge%3A%20mean%20difference%3A%2012%20%25%3B%2095%20%25%20CI%3A%207.3-18.5%3B%20p%20%26lt%3B%200.001%3B%20SDM%20judging%20ability%20%28inter-rater%20concordance%20displayed%20by%20weighted%20t%29%3A%20mean%20difference%3A%200.07%3B%2095%20%25CI%3A%200.03-0.11%3B%20p%20%3D%200.001%29.%20Feedback%20was%20positive.%5CnCONCLUSION%3A%20The%20online%20training%20with%20its%20distinctive%20methodology%20prove%20effective.%20As%20it%20shares%20the%20theoretical%20and%20didactical%20background%20with%20an%20already%20existing%20face-to-face%20training%2C%20both%20approaches%20may%20also%20be%20used%20complementarily.%5CnPRACTICE%20IMPLICATIONS%3A%20SDM%20can%20be%20trained%20effectively%20and%20efficiently%20with%20this%20easily%20scalable%20online%20training.%22%2C%22date%22%3A%222020-11-27%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.pec.2020.11.033%22%2C%22ISSN%22%3A%221873-5134%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZFT52UPQ%22%2C%2246NNKHWR%22%2C%223L4EXKAR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%227C3HQD4E%22%2C%22ZKMQLZWF%22%5D%2C%22dateModified%22%3A%222024-05-17T09%3A18%3A13Z%22%7D%7D%2C%7B%22key%22%3A%2299M85N58%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Matzdorff%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMatzdorff%2C%20Axel%2C%20Jens%20U.%20R%5Cu00fcffer%2C%20and%20Oliver%20Meyer.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fblood-2020-134331%26%23039%3B%26gt%3BFrom%20Fatigue%20Surveys%20to%20Survey%20Fatigue%20-%20Notes%20from%20Daily%20Hematology%20Practice%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BBlood%26lt%3B%5C%2Fi%26gt%3B%20136%2C%20no.%20Supplement%201%20%28November%205%2C%202020%29%3A%2039%5Cu201339.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22From%20Fatigue%20Surveys%20to%20Survey%20Fatigue%20-%20Notes%20from%20Daily%20Hematology%20Practice%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Axel%22%2C%22lastName%22%3A%22Matzdorff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%22%2C%22lastName%22%3A%22Meyer%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Monitoring%20fever%2C%20pain%2C%20and%20nausea%20has%20become%20a%20daily%20routine%20in%20hematology%20and%20oncology%20practice.%20Fatigue%20is%20also%20common%20but%20thematized%20much%20less%20often.%20Therefore%2C%20guidelines%20and%20professional%20organizations%20recommend%20implementing%20fatigue%20assessment%20in%20daily%20oncology%20practice.%20The%20current%20deficits%20can%20be%20explained%20by%20diverging%20scientific%20concepts%2C%20inconsistent%20definitions%2C%20and%20lack%20of%20consensus%20on%20measurement%20and%20therapy.%20As%20a%20quality%20improvement%20initiative%20and%20first%20step%20towards%20better%20fatigue%20assessment%20we%20wanted%20to%20find%20out%20which%20fatigue%20questionnaire%20is%20best%20suited%20for%20our%20patients.Methods%3A%20On%20two%20educational%20meetings%20on%20general%20oncology%20issues%20we%20invited%20patients%20and%20healthy%20controls%20to%20participate%20in%20an%20anonymous%20survey.%20We%20distributed%20three%20different%20fatigue%20questionnaires%20%28Fatigue%20Assessment%20Scale%20-%20FAS%2C%20Functional%20Assessment%20of%20Cancer%20Therapy-Fatigue-Scale%20-%20FACT-F%2C%20EORTC%20questionnaire%20on%20cancer%20related%20fatigue%20-%20EORTC%20QLQ-FA12%2C%20one%20for%20each%20participant%29%20and%20asked%20to%20rate%20the%20questionnaires%20on%20a%205-point%20scale%20%281%3D%20fitting%20best%20to%205%20%3D%20not%20fitting%29.%20We%20also%20counted%20the%20number%20of%20questions%20that%20had%20been%20left%20blank.Results%3A%20Seventy-seven%20of%2090%20questionnaires%20were%20returned%20%2885%25%29.%20The%20average%20approval%20rating%20of%20the%20FAS%20questionnaire%20was%202.3%20%28patients%20n%3D10%2C%20score%202.0%3B%20controls%20n%3D35%2C%20score%202.3%29%2C%20of%20EORTC%20QLQ-FA12%202.4%20%28patients%20n%3D8%2C%20score%202.4%3B%20controls%20n%3D8%2C%20score%202.4%29%2C%20and%20of%20FACT-F%202.1%20%28patients%20n%3D9%2C%20score%202.0%3B%20controls%20n%3D7%2C%20score%202.3%29.%20The%20percentage%20of%20questions%20that%20had%20been%20left%20blank%20with%20FAS%20was%200.5%25%2C%203%25%20with%20EORTC%20QLQ-FA12%2C%20and%2014%25%20with%20FACT-F.Conclusion%3A%20This%20survey%20did%20not%20measure%20fatigue%20and%20we%20do%20not%20know%20how%20many%20of%20our%20patients%20had%20fatigue.%20Its%20purpose%20was%20to%20assess%20the%20acceptance%20of%20three%20different%20fatigue%20questionnaires.%20The%20unexpected%20finding%20was%20that%20the%20average%20rating%20of%20all%20three%20questionnaires%20was%20remarkably%20similar%20and%20close%20to%20neutral.%20The%20number%20of%20blanks%20was%20highest%20with%20the%20EORTC%20QLQ-FA12%20questionnaire%20which%20had%20more%20items%20than%20the%20two%20others.%20One%20explanation%20could%20be%2C%20that%20participants%20do%20not%20value%20questionnaires%20when%20they%20are%20long%20%28%26quot%3Bsurvey%20fatigue%26quot%3B%29.%20Maybe%20participants%20perceive%20fatigue%20as%20a%20personal%20failure%20and%20do%20not%20want%20to%20reveal%20this%20on%20a%20questionnaire%2C%20particularly%20not%20when%20there%20is%20a%20chance%20that%20this%20goes%20into%20their%20patient%20file.%20Questionnaires%20were%20developed%20for%20scientific%20research%20but%20might%20not%20be%20the%20right%20instrument%20to%20thematize%20fatigue%20in%20the%20setting%20of%20a%20busy%20hemato-oncology%20practice.Matzdorff%3ANovartis%20Oncology%3A%20Consultancy%2C%20Other%3A%20Honoraria%20paid%20to%20institution%3B%20Amgen%20GmbH%3A%20Consultancy%2C%20Other%3A%20Honoraria%20paid%20to%20institution%3B%20Grifols%20Deutschland%20GmbH%3A%20Consultancy%2C%20Other%3A%20Honoraria%20paid%20to%20institution%3B%20Swedish%20Orphan%20Biovitrium%20GmbH%3A%20Consultancy%2C%20Other%3A%20Honoraria%20paid%20to%20institution%3B%20UCB%20Biopharma%20SRL%3A%20Consultancy%2C%20Other%3A%20Honoraria%20paid%20to%20institution%3B%20Roche%20Pharma%20AG%3A%20Other%3A%20Family%20stockownership.%20Meyer%3AGrifols%20Germany%3A%20Consultancy%2C%20Honoraria%3B%20Amgen%20GmbH%3A%20Honoraria%3B%20Novartis%20Pharma%20GmbH%3A%20Honoraria.%22%2C%22date%22%3A%22November%205%2C%202020%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1182%5C%2Fblood-2020-134331%22%2C%22ISSN%22%3A%220006-4971%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fblood-2020-134331%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22SPWXRLZV%22%2C%22W637CI9M%22%2C%22P9CVNWVH%22%5D%2C%22dateModified%22%3A%222025-05-18T08%3A08%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22MLMQ3F4X%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Danner%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDanner%2C%20Marion%2C%20Friedemann%20Geiger%2C%20Kai%20Wehkamp%2C%20Jens%20Ulrich%20Rueffer%2C%20Christine%20Kuch%2C%20Leonie%20Sundmacher%2C%20Tove%20Skjelbakken%2C%20et%20al.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fbmjopen.bmj.com%5C%2Fcontent%5C%2F10%5C%2F10%5C%2Fe037575%26%23039%3B%26gt%3BMaking%20shared%20decision-making%20%28SDM%29%20a%20reality%3A%20protocol%20of%20a%20large-scale%20long-term%20SDM%20implementation%20programme%20at%20a%20Northern%20German%20University%20Hospital%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BBMJ%20Open%26lt%3B%5C%2Fi%26gt%3B%2010%2C%20no.%2010%20%28October%201%2C%202020%29%3A%20e037575.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2020-037575.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Making%20shared%20decision-making%20%28SDM%29%20a%20reality%3A%20protocol%20of%20a%20large-scale%20long-term%20SDM%20implementation%20programme%20at%20a%20Northern%20German%20University%20Hospital%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marion%22%2C%22lastName%22%3A%22Danner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedemann%22%2C%22lastName%22%3A%22Geiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Wehkamp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22Rueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Kuch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonie%22%2C%22lastName%22%3A%22Sundmacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tove%22%2C%22lastName%22%3A%22Skjelbakken%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Rummer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Novelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Debrouwere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fueloep%22%2C%22lastName%22%3A%22Scheibler%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%20Shared%20decision-making%20%28SDM%29%20is%20not%20yet%20widely%20used%20when%20making%20decisions%20in%20German%20hospitals.%20Making%20SDM%20a%20reality%20is%20a%20complex%20task.%20It%20involves%20training%20healthcare%20professionals%20in%20SDM%20communication%20and%20enabling%20patients%20to%20actively%20participate%20in%20communication%2C%20in%20addition%20to%20providing%20sound%2C%20easy%20to%20understand%20information%20on%20treatment%20alternatives%20in%20the%20form%20of%20evidence-based%20patient%20decision%20aids%20%28EbPDAs%29.%20This%20project%20funded%20by%20the%20German%20Innovation%20Fund%20aims%20at%20designing%2C%20implementing%20and%20evaluating%20a%20multicomponent%2C%20large-scale%20and%20integrative%20SDM%20programme%5Cu2014called%20SHARE%20TO%20CARE%20%28S2C%29%5Cu2014at%20all%20clinical%20departments%20of%20a%20University%20Hospital%20Campus%20in%20Northern%20Germany%20within%20a%204-year%20time%20period.%5CnMethods%20and%20analysis%20S2C%20tackles%20the%20aforementioned%20components%20of%20SDM%3A%20%281%29%20training%20physicians%20in%20SDM%20communication%2C%20%282%29%20activating%20and%20empowering%20patients%2C%20%283%29%20developing%20EbPDAs%20in%20the%20most%20common%5C%2Frelevant%20diseases%20and%20%284%29%20training%20other%20healthcare%20professionals%20in%20SDM%20coaching.%20S2C%20is%20designed%20together%20with%20patients%20and%20providers.%20The%20physicians%5Cu2019%20training%20programme%20entails%20an%20online%20and%20an%20in%20situ%20training%20module.%20The%20decision%20coach%20training%20is%20based%20on%20a%20similar%20but%20less%20comprehensive%20approach.%20The%20development%20of%20online%20EbPDAs%20follows%20the%20International%20Patient%20Decision%20Aid%20Standards%20and%20includes%20written%2C%20graphical%20and%20video-based%20information.%20Validated%20outcomes%20of%20SDM%20implementation%20are%20measured%20in%20a%20preintervention%20and%20postintervention%20evaluation%20design.%20Process%20evaluation%20accompanies%20programme%20implementation.%20Health%20economic%20impact%20of%20the%20intervention%20is%20investigated%20using%20a%20propensity-score-matched%20approach%20based%20on%20potentially%20preference-sensitive%20hospital%20decisions.%5CnEthics%20and%20dissemination%20Ethics%20committee%20review%20approval%20has%20been%20obtained%20from%20Medical%20Ethics%20Committee%20of%20the%20Medical%20Faculty%20of%20the%20Christian-Albrechts-University%20Kiel.%20Project%20information%20and%20results%20will%20be%20disseminated%20at%20conferences%2C%20on%20project-hosted%20websites%20at%20University%20Hospital%20Medical%20Center%20Schleswig%20Holstein%20and%20by%20S2C%20as%20well%20as%20in%20peer-reviewed%20and%20professional%20journals.%22%2C%22date%22%3A%222020%5C%2F10%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2020-037575%22%2C%22ISSN%22%3A%222044-6055%2C%202044-6055%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fbmjopen.bmj.com%5C%2Fcontent%5C%2F10%5C%2F10%5C%2Fe037575%22%2C%22collections%22%3A%5B%22ZAW5JYVL%22%2C%22ZFT52UPQ%22%2C%2246NNKHWR%22%2C%223L4EXKAR%22%2C%22J987ELTY%22%2C%22SPWXRLZV%22%2C%227C3HQD4E%22%2C%22ZKMQLZWF%22%2C%22DCC2W2YR%22%2C%227ZDA33V6%22%2C%22P9CVNWVH%22%2C%22ERQ322N6%22%5D%2C%22dateModified%22%3A%222024-05-17T08%3A59%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22VTZQFUVQ%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kreissl%20et%20al.%22%2C%22parsedDate%22%3A%222020-09-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKreissl%2C%20Stefanie%2C%20Horst%20M%26%23xFC%3Bller%2C%20Helen%20Goergen%2C%20Julia%20Meissner%2C%20Max%20Topp%2C%20Martin%20S%26%23xF6%3Bkler%2C%20Jana%20Markova%2C%20et%20al.%20%26%23x201C%3BHealth-Related%20Quality%20of%20Life%20in%20Patients%20With%20Hodgkin%20Lymphoma%3A%20A%20Longitudinal%20Analysis%20of%20the%20German%20Hodgkin%20Study%20Group.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Clinical%20Oncology%3A%20Official%20Journal%20of%20the%20American%20Society%20of%20Clinical%20Oncology%26lt%3B%5C%2Fi%26gt%3B%2038%2C%20no.%2025%20%28September%201%2C%202020%29%3A%202839%26%23x2013%3B48.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1200%5C%2FJCO.19.03160%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1200%5C%2FJCO.19.03160%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Health-Related%20Quality%20of%20Life%20in%20Patients%20With%20Hodgkin%20Lymphoma%3A%20A%20Longitudinal%20Analysis%20of%20the%20German%20Hodgkin%20Study%20Group%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefanie%22%2C%22lastName%22%3A%22Kreissl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Horst%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Goergen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Meissner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Max%22%2C%22lastName%22%3A%22Topp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22S%5Cu00f6kler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jana%22%2C%22lastName%22%3A%22Markova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00fcrg%22%2C%22lastName%22%3A%22Bernhard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Greil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bastian%22%2C%22lastName%22%3A%22von%20Tresckow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karolin%22%2C%22lastName%22%3A%22Behringer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens-Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans-Henning%22%2C%22lastName%22%3A%22Flechtner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michaela%22%2C%22lastName%22%3A%22M%5Cu00f6stl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Fuchs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Engert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Volker%22%2C%22lastName%22%3A%22Diehl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Borchmann%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Many%20important%20details%20of%20health-related%20quality%20of%20life%20%28HRQoL%29%20after%20diagnosis%20and%20treatment%20of%20Hodgkin%20lymphoma%20%28HL%29%20are%20still%20unknown%20because%20large%20longitudinal%20studies%20of%20HRQoL%20are%20rare.%20Therefore%2C%20we%20analyzed%20a%20systematically%20assessed%2C%20comprehensive%20range%20of%20HRQoL%20domains%20in%20patients%20with%20HL%20of%20all%20stages%20from%20diagnosis%20up%20to%205%20years%20of%20survivorship.%5CnPATIENTS%20AND%20METHODS%3A%20We%20included%20patients%20with%20HL%20age%2018-60%20years%20at%20diagnosis%20from%20the%20German%20Hodgkin%20Study%20Group%20trials%20HD13%2C%20HD14%2C%20and%20HD15.%20We%20analyzed%20HRQoL%20using%20all%20functional%20and%20symptom%20scales%20of%20the%20European%20Organisation%20for%20Research%20and%20Treatment%20of%20Cancer%20Quality%20of%20Life%20Questionnaire%20C30%20including%20deviations%20from%20reference%20values.%20We%20estimated%20the%20effect%20of%20different%20disease%2C%20patient%2C%20and%20treatment%20characteristics%20using%20multiple%20regression%20and%20repeated%20measures%20analysis%20and%20computed%20correlations%20of%20HRQoL%20scores.%5CnRESULTS%3A%20We%20analyzed%204%2C215%20patients%20with%20any%20HRQoL%20assessment%20within%205%20years%20after%20treatment.%20Higher%20tumor%20burden%20at%20diagnosis%20was%20associated%20with%20impaired%20baseline%20scores%20in%20many%20HRQoL%20domains.%20During%20survivorship%2C%20cognitive%2C%20emotional%2C%20role%2C%20and%20social%20functioning%20and%20fatigue%2C%20dyspnea%2C%20sleep%2C%20and%20financial%20problems%20were%20severely%20and%20persistently%20affected.%20From%20year%202%20on%2C%20mean%20deviations%20from%20reference%20values%20ranged%20between%2012%20and%2029%20points%2C%20with%2010%20points%20being%20a%20commonly%20used%20margin%20of%20clinical%20relevance.%20In%20all%203%20trials%2C%20HRQoL%20domains%202%20and%205%20years%20after%20therapy%20were%20significantly%20influenced%20by%20baseline%20scores%20and%20age%20but%20not%20by%20randomized%20treatments.%20Fatigue%20was%20most%20closely%20correlated%20with%20other%20symptoms%20and%20scales.%5CnCONCLUSION%3A%20Our%20results%20show%20a%20high%20and%20persistent%20amount%20of%20different%20HRQoL%20deficits%20in%20survivors%20of%20HL%20that%20are%20largely%20independent%20of%20the%20applied%20chemotherapies.%20Our%20analysis%20underscores%20the%20high%2C%20unmet%20medical%20need%20of%20these%20rather%20young%20survivors%20of%20HL%20regarding%20the%20psychosocial%20adverse%20effects%20of%20the%20cancer%20experience.%22%2C%22date%22%3A%22Sep%2001%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1200%5C%2FJCO.19.03160%22%2C%22ISSN%22%3A%221527-7755%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22W637CI9M%22%2C%22N24UXA6K%22%5D%2C%22dateModified%22%3A%222024-06-05T15%3A15%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22LPV2H4FE%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lohmann%20and%20R%5Cu00fcffer%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLohmann%2C%20Michael%2C%20and%20Jens%20Ulrich%20R%5Cu00fcffer.%20%26lt%3Bi%26gt%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fd-nb.info%5C%2F1213826160%26%23039%3B%26gt%3BWenn%20eine%20Begegnung%20alles%20ver%5Cu00e4ndert%3A%20%5Cu00c4rztinnen%20und%20%5Cu00c4rzte%20erz%5Cu00e4hlen%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fi%26gt%3B.%201.%20Auflage.%20K%5Cu00f6ln%3A%20atp%20Verlag%2C%202020.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22book%22%2C%22title%22%3A%22Wenn%20eine%20Begegnung%20alles%20ver%5Cu00e4ndert%3A%20%5Cu00c4rztinnen%20und%20%5Cu00c4rzte%20erz%5Cu00e4hlen%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Lohmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22ger%22%2C%22ISBN%22%3A%22978-3-943064-20-9%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fd-nb.info%5C%2F1213826160%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22LSGM8V2E%22%2C%22J987ELTY%22%2C%22SPWXRLZV%22%2C%22QXIGN3AI%22%5D%2C%22dateModified%22%3A%222024-06-06T04%3A56%3A32Z%22%7D%7D%2C%7B%22key%22%3A%2236DNZ8CU%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%22%2C%22parsedDate%22%3A%222019-12-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%5Cu00fcffer%2C%20Jens%20Ulrich.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs15015-019-0719-9%26%23039%3B%26gt%3BCrF%2C%20ein%20Symptomkomplex%20mit%20vielen%20Implikationen%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BIm%20Fokus%20Onkologie%26lt%3B%5C%2Fi%26gt%3B%2022%2C%20no.%206%20%28December%201%2C%202019%29%3A%2073%5Cu201377.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22CrF%2C%20ein%20Symptomkomplex%20mit%20vielen%20Implikationen%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%5D%2C%22abstractNote%22%3A%22Nahezu%20alle%20Tumorpatienten%20entwickeln%20im%20Verlauf%20ihrer%20Erkrankung%20eine%20tumorassoziierte%20Fatigue.%20Zum%20Teil%20besteht%20diese%20schon%20zum%20Diagnosezeitpunkt%20und%20oft%20begleitet%20sie%20den%20Patienten%20auch%20lange%20%5Cu00fcber%20eine%20erfolgreiche%20Therapie%20hinaus.%20Erkennen%2C%20behandeln%20und%20unterst%5Cu00fctzen%20sind%20die%20wesentlichen%20Eckpunkte%20f%5Cu00fcr%20eine%20gute%20Betreuung%20von%20Fatigue%20Betroffenen.%22%2C%22date%22%3A%222019-12-01%22%2C%22language%22%3A%22de%22%2C%22DOI%22%3A%2210.1007%5C%2Fs15015-019-0719-9%22%2C%22ISSN%22%3A%222192-5674%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs15015-019-0719-9%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A55%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22P4UL4XJ2%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kuipers%20et%20al.%22%2C%22parsedDate%22%3A%222019-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKuipers%2C%20J.%20G.%2C%20M.%20Koller%2C%20F.%20Zeman%2C%20K.%20M%26%23xFC%3Bller%2C%20and%20J.%20U.%20R%26%23xFC%3Bffer.%20%26%23x201C%3BAdh%26%23xE4%3Brenz%20Und%20Gesundheitskommunikationskompetenz%20in%20Bezug%20Auf%20Das%20Therapieergebnis%20Bei%20Patienten%20Mit%20Rheumatoider%20Arthritis.%26%23x201D%3B%20%26lt%3Bi%26gt%3BZeitschrift%20Fur%20Rheumatologie%26lt%3B%5C%2Fi%26gt%3B%2078%2C%20no.%201%20%28February%202019%29%3A%2074%26%23x2013%3B81.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00393-018-0449-y%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00393-018-0449-y%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adh%5Cu00e4renz%20und%20Gesundheitskommunikationskompetenz%20in%20Bezug%20auf%20das%20Therapieergebnis%20bei%20Patienten%20mit%20rheumatoider%20Arthritis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20G.%22%2C%22lastName%22%3A%22Kuipers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Koller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Zeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Disabilities%20in%20daily%20living%20and%20quality%20of%20life%20are%20key%20endpoints%20for%20evaluating%20the%20treatment%20outcome%20for%20rheumatoid%20arthritis%20%28RA%29.%20Factors%20possibly%20contributing%20to%20good%20outcome%20are%20adherence%20and%20health%20literacy.%5CnMETHODS%3A%20The%20survey%20included%20a%5Cu00a0representative%20nationwide%20sample%20of%20German%20rheumatologists%20and%20their%20patients%20with%20RA.%20The%20physician%20questionnaire%20included%20the%20disease%20activity%20score%20%28DAS28%29%20and%20medical%20prescriptions.%20The%20patient%20questionnaire%20included%20fatigue%20%28EORTC%20QLQ-FA13%29%2C%20health%20assessment%20questionnaire%20%28HAQ%29%2C%20quality%20of%20life%20%28SF-12%29%2C%20health%20literacy%20%28HELP%29%2C%20and%20patients%26%23039%3B%20listings%20of%20their%20medications.%20Adherence%20was%20operationalized%20as%20follows%3A%20patient-reported%20%28CQR5%29%2C%20behavioral%20%28concordance%20between%20physicians%26%23039%3B%20and%20patients%26%23039%3B%20listings%20of%20medications%29%2C%20physician-assessed%2C%20and%20a%5Cu00a0combined%20measure%20of%20physician%20rating%20%281%5Cu202f%3D%5Cu2009very%20adherent%2C%200%5Cu202f%3D%5Cu2009less%20adherent%29%20and%20the%20match%20between%20physicians%26%23039%3B%20prescriptions%20and%20patients%26%23039%3B%20accounts%20of%20their%20medications%20%281%5Cu202f%3D%5Cu2009perfect%20match%2C%200%5Cu202f%3D%5Cu2009no%20perfect%20match%29%20that%20yielded%20three%20categories%20of%20adherence%3A%20high%2C%20medium%2C%20and%20low.%20Simple%20and%20multiple%20linear%20regressions%20%28controlling%20for%20age%2C%20sex%2C%20smoking%2C%20drinking%20alcohol%2C%20and%20sport%29%20were%20calculated%20using%20adherence%20and%20health%20literacy%20as%20predictor%20variables%2C%20and%20disease%20activity%20and%20patient-reported%20outcomes%20as%20dependent%20variables.%5CnRESULTS%3A%20708%20pairs%20of%20patient%20and%20physician%20questionnaires%20were%20analyzed.%20The%20mean%20patient%20age%20%2873%25%20women%29%20was%2060%5Cu00a0years%20%28SD%5Cu202f%3D%5Cu200912%29.%20Multiple%20regression%20analyses%20showed%20that%20high%20adherence%20was%20significantly%20associated%20with%205%5C%2F7%20outcome%20variables%20and%20health%20literacy%20with%207%5C%2F7%20outcome%20variables.%5CnCONCLUSION%3A%20Adherence%20and%20health%20literacy%20had%20weak%20but%20consistent%20effects%20on%20most%20outcomes.%20Thus%2C%20enhancing%20adherence%20and%20understanding%20of%20medical%20information%20could%20improve%20outcome%2C%20which%20should%20be%20investigated%20in%20future%20interventional%20studies.%22%2C%22date%22%3A%22Feb%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00393-018-0449-y%22%2C%22ISSN%22%3A%221435-1250%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22SPWXRLZV%22%2C%22SG8SD8IJ%22%2C%228B2HH96K%22%2C%22XSMILFVY%22%2C%22N24UXA6K%22%5D%2C%22dateModified%22%3A%222024-06-06T02%3A49%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22IPUIQQCL%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%20et%20al.%22%2C%22parsedDate%22%3A%222018-04-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%5Cu00fcffer%2C%20Jens%20Ulrich%2C%20Hans%20Henning%20Flechtner%2C%20and%20Peter%20Borchmann.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00761-018-0356-5%26%23039%3B%26gt%3BPsychosoziale%20Belastung%20und%20Lebensqualit%5Cu00e4t%20nach%20Morbus%20Hodgkin%3A%20Kein%20Ende%20der%20Erfassung%20%5Cu2013%20noch%20kein%20Anfang%20der%20patientenzentrierten%20Intervention%3F%26lt%3B%5C%2Fa%26gt%3B%26quot%3B%20%26lt%3Bi%26gt%3BDer%20Onkologe%26lt%3B%5C%2Fi%26gt%3B%2024%2C%20no.%204%20%28April%201%2C%202018%29%3A%20335%5Cu201339.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Psychosoziale%20Belastung%20und%20Lebensqualit%5Cu00e4t%20nach%20Morbus%20Hodgkin%3A%20Kein%20Ende%20der%20Erfassung%20%5Cu2013%20noch%20kein%20Anfang%20der%20patientenzentrierten%20Intervention%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%20Henning%22%2C%22lastName%22%3A%22Flechtner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Borchmann%22%7D%5D%2C%22abstractNote%22%3A%22Nachdem%20es%20in%20der%20Behandlung%20des%20Morbus%20Hodgkin%20in%20den%20letzten%20Jahrzehnten%20gro%5Cu00dfe%20Fortschritte%20gab%2C%20r%5Cu00fccken%20nun%20die%20Fragen%20im%20Gefolge%20des%20Langzeit%5Cu00fcberlebens%20dieser%20Patienten%20in%20den%20Vordergrund.%20Neben%20Nebenwirkungsprofilen%20und%20langfristigem%20Behandlungserfolg%20stellen%20sich%20viele%20Fragen%20zu%20Lebensqualit%5Cu00e4t%2C%20Fatigue%2C%20psychischen%20Folgen%20wie%20Depression%2C%20Fertilit%5Cu00e4t%2C%20Berufseingliederung%20und%20auch%20Aufkl%5Cu00e4rung.%20Trotz%20mittlerweile%20gro%5Cu00dfer%20Datens%5Cu00e4tze%20zu%20patientenbezogenen%20Ergebnisma%5Cu00dfen%20gehen%20diese%20Informationen%20noch%20kaum%20systematisch%20in%20die%20Patientenbetreuung%20ein%20und%20haben%20auch%20keine%20Auswirkungen%20auf%20die%20traditionellen%20Nachsorgekonzepte.%20Hier%20sind%20nun%20innovative%20Ans%5Cu00e4tze%20gefragt%2C%20die%20unter%20Einsatz%20von%20modernen%20Medien%20die%20Patienten%20sehr%20viel%20st%5Cu00e4rker%20miteinbeziehen%20und%20f%5Cu00fcr%20diese%20junge%20Patientengruppe%20relevante%20Aspekte%20der%20Lebensplanung%20aufgreifen.%20Grundz%5Cu00fcge%20dieser%20Situation%20werden%20dargestellt%20und%20diskutiert.%22%2C%22date%22%3A%222018-04-01%22%2C%22language%22%3A%22de%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00761-018-0356-5%22%2C%22ISSN%22%3A%221433-0415%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00761-018-0356-5%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A55%3A28Z%22%7D%7D%2C%7B%22key%22%3A%222RDCB24E%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Romotzky%20et%20al.%22%2C%22parsedDate%22%3A%222018-03-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRomotzky%2C%20Vanessa%2C%20Julia%20Strupp%2C%20Alexander%20Hayn%2C%20Jens%20Ulrich%20R%26%23xFC%3Bffer%2C%20Judith%20Gr%26%23xFC%3Bmmer%2C%20and%20Raymond%20Voltz.%20%26%23x201C%3B%26%23x2018%3BAll%20of%20a%20Sudden%2C%20a%20Lot%20Less%20Still%20Makes%20It%20Worthwhile%20to%20Be%20Alive%3A%26%23x2019%3B%20Palliative%20Care%20Patients%26%23x2019%3B%20Views%20on%20Life.%26%23x201D%3B%20%26lt%3Bi%26gt%3BPalliative%20%26amp%3B%20Supportive%20Care%26lt%3B%5C%2Fi%26gt%3B%2C%20March%208%2C%202018%2C%201%26%23x2013%3B7.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1017%5C%2FS1478951518000081%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1017%5C%2FS1478951518000081%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22%5C%22All%20of%20a%20sudden%2C%20a%20lot%20less%20still%20makes%20it%20worthwhile%20to%20be%20alive%3A%5C%22%20Palliative%20care%20patients%27%20views%20on%20life%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Romotzky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Strupp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Hayn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Gr%5Cu00fcmmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%22%2C%22lastName%22%3A%22Voltz%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20We%20aimed%20to%20elucidate%20the%20views%20on%20life%20as%20narrated%20by%20patients%20in%20palliative%20care%20%28PC%29%20to%20find%20out%20what%20patients%20deem%20to%20be%20essential%20in%20their%20life%2C%20whether%20something%20has%20changed%20concerning%20their%20view%20of%20life%20in%20light%20of%20the%20disease%2C%20and%20whether%20interviewees%20would%20like%20to%20give%20others%20something%20to%20take%20with%20them.%5CnMETHOD%3A%20Data%20were%20collected%20from%20narrative%20audio%20and%20video%20interviews%20with%2018%20inpatients%20in%20a%20specialized%20PC%20unit.%20Interviews%20were%20recorded%20and%20transcribed%20verbatim%20and%20analyzed%20using%20qualitative%20content%20analysis%20applying%20MAXQDA%20software.%20CDs%20and%20DVDs%20with%20recorded%20interviews%20were%20provided%20to%20patients.%20Result%20Eighteen%20interviews%20were%20analyzed%3A%2011%20audio%20and%207%20video%20recordings.%20The%20age%20range%20was%2041-80%20years.%20Patients%20reported%20on%20changes%20in%20their%20views%20on%20life.%20Despite%20it%20being%20a%20complex%20and%20painful%20process%2C%20patients%20still%20gave%20examples%20of%20benefits%20experienced%20during%20their%20illness%20trajectory.%20Patients%20identified%20resources%20and%20coping%20strategies%20such%20as%20meaningful%20contacts%20with%20close%20others%20and%20mindfulness.%20Shifts%20have%20occurred%20in%20terms%20of%20taking%20more%20time%20for%20themselves%2C%20enjoying%20the%20moment%2C%20being%20more%20calm%2C%20and%20spending%20more%20time%20with%20family%20and%20friends.%20What%20patients%20wanted%20to%20pass%20on%20to%20others%20was%20to%20pay%20attention%20to%20the%20needs%20of%20both%20the%20self%20and%20the%20others%2C%20shape%20your%20life%20individually%2C%20confront%20yourself%20early%20with%20issues%20of%20death%20and%20dying%2C%20and%20care%20for%20your%20fellow%20human%20beings.%20Patients%20and%20relatives%20valued%20the%20opportunity%20to%20keep%20their%20interview%20as%20a%20CD%5C%2FDVD.%20Significance%20of%20results%20Results%20support%20the%20idea%20that%20many%20people%20facing%20terminal%20illness%20continue%20to%20focus%20on%20living%20and%20remain%20within%20their%20biographies%20and%20the%20contexts%20of%20their%20lives%2C%20even%20if%20their%20functional%20status%20declines.%20Patients%20and%20relatives%20appreciated%20that%20interviews%20were%20provided%20as%20kind%20of%20a%20legacy.%20Yet%2C%20more%20robust%20research%20is%20needed%20to%20decide%20whether%20such%20interviews%20yield%20any%20therapeutic%20effect.%22%2C%22date%22%3A%22Mar%2008%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1017%5C%2FS1478951518000081%22%2C%22ISSN%22%3A%221478-9523%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22LSGM8V2E%22%2C%22S488ZYK4%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22BEQ38XPW%22%2C%2299FDCW4Z%22%5D%2C%22dateModified%22%3A%222024-05-15T09%3A05%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22N9QWN94C%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kreissl%20et%20al.%22%2C%22parsedDate%22%3A%222018-02-19%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKreissl%2C%20Stefanie%2C%20C%20B%5Cu00fcrkle%2C%20Jens%20Ulrich%20R%5Cu00fcffer%2C%20Anja%20Mehnert%2C%20and%20Peter%20Borchmann.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.springermedizin.de%5C%2Fhodgkin-lymphom%5C%2Ftumorbedingte-fatigue%5C%2Ftumorassoziierte-fatigue-beim-hodgkin-lymphom%5C%2F15474398%26%23039%3B%26gt%3BTumorassoziierte%20Fatigue%20beim%20Hodgkin-Lymphom%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BOnkologe%26lt%3B%5C%2Fi%26gt%3B%204%2C%20no.%202018%20%28February%2019%2C%202018%29%3A%204.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tumorassoziierte%20Fatigue%20beim%20Hodgkin-Lymphom%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefanie%22%2C%22lastName%22%3A%22Kreissl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22B%5Cu00fcrkle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anja%22%2C%22lastName%22%3A%22Mehnert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Borchmann%22%7D%5D%2C%22abstractNote%22%3A%22Die%20Lebensqualit%5Cu00e4t%20junger%20Langzeit%5Cu00fcberlebender%5Cu00a0eines%20Hodgkin-Lymphoms%20wird%20u.%20a.%20durch%20tumorassoziierte%20Fatigue%20%28CrF%29%5Cu00a0beeintr%5Cu00e4chtigt.%20Ein%20%5Cu00dcberblick%20%5Cu00fcber%20H%5Cu00e4ufigkeit%2C%20Entwicklung%20und%20Verlauf%20der%20CrF%20beim%20Hodgkin-Lymphom%2C%20langfristige%20Folgen%20f%5Cu00fcr%20die%20soziale%20Reintegration%20und%20therapeutische%20Optionen.%22%2C%22date%22%3A%222018-02-19%22%2C%22language%22%3A%22de%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.springermedizin.de%5C%2Fhodgkin-lymphom%5C%2Ftumorbedingte-fatigue%5C%2Ftumorassoziierte-fatigue-beim-hodgkin-lymphom%5C%2F15474398%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A32%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22GR9B8YGV%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fischer%20et%20al.%22%2C%22parsedDate%22%3A%222017-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFischer%2C%20I.%2C%20J.%20Weis%2C%20J.%20U.%20R%5Cu00fcffer%2C%20M.%20Heim%2C%20P.%20Bojko%2C%20and%20C.%20Ostgathe.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fwww.thieme-connect.de%5C%2FDOI%5C%2FDOI%3F10.1055%5C%2Fs-0042-124041%26%23039%3B%26gt%3BTumorassoziierte%20Fatigue%20in%20der%20Palliativsituation%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BZeitschrift%20f%5Cu00fcr%20Palliativmedizin%26lt%3B%5C%2Fi%26gt%3B%2018%2C%20no.%202%20%28March%202017%29%3A%2097%5Cu2013110.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1055%5C%2Fs-0042-124041.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tumorassoziierte%20Fatigue%20in%20der%20Palliativsituation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Weis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Heim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Bojko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Ostgathe%22%7D%5D%2C%22abstractNote%22%3A%22Tumorassoziierte%20Fatigue%20%28Cancer-related%20Fatigue%2C%20CrF%29%20ist%2C%20auch%20in%20der%20Palliativsituation%2C%20ein%20h%5Cu00e4ufiger%2C%20die%20Alltagsfunktionalit%5Cu00e4t%2C%20die%20Lebensqualit%5Cu00e4t%20und%20die%20Lebenserwartung%20schwer%20beeintr%5Cu00e4chtigender%20Zustand%20von%20M%5Cu00fcdigkeit%20und%20Ersch%5Cu00f6pfung.%20Um%20das%20Chronifizierungsrisiko%20zu%20reduzieren%2C%20sollte%20CrF%20fr%5Cu00fchzeitig%20wahrgenommen%20und%20behandelt%20werden.%20Die%20diagnostischen%20M%5Cu00f6glichkeiten%20und%20die%20Therapieoptionen%20werden%20in%20diesem%20Beitrag%20vorgestellt.%22%2C%22date%22%3A%222017%5C%2F03%22%2C%22language%22%3A%22de%22%2C%22DOI%22%3A%2210.1055%5C%2Fs-0042-124041%22%2C%22ISSN%22%3A%221615-2921%2C%201615-293X%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.thieme-connect.de%5C%2FDOI%5C%2FDOI%3F10.1055%5C%2Fs-0042-124041%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A54%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22XAKP9H9S%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Loebel%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLoebel%2C%20Madlen%2C%20Maren%20Eckey%2C%20Franziska%20Sotzny%2C%20Elisabeth%20Hahn%2C%20Sandra%20Bauer%2C%20Patricia%20Grabowski%2C%20Johannes%20Zerweck%2C%20et%20al.%20%26%23x201C%3BSerological%20Profiling%20of%20the%20EBV%20Immune%20Response%20in%20Chronic%20Fatigue%20Syndrome%20Using%20a%20Peptide%20Microarray.%26%23x201D%3B%20%26lt%3Bi%26gt%3BPloS%20One%26lt%3B%5C%2Fi%26gt%3B%2012%2C%20no.%206%20%282017%29%3A%20e0179124.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0179124%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0179124%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Serological%20profiling%20of%20the%20EBV%20immune%20response%20in%20Chronic%20Fatigue%20Syndrome%20using%20a%20peptide%20microarray%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madlen%22%2C%22lastName%22%3A%22Loebel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maren%22%2C%22lastName%22%3A%22Eckey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franziska%22%2C%22lastName%22%3A%22Sotzny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Hahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Bauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Grabowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%22%2C%22lastName%22%3A%22Zerweck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pavlo%22%2C%22lastName%22%3A%22Holenya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leif%20G.%22%2C%22lastName%22%3A%22Hanitsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kirsten%22%2C%22lastName%22%3A%22Wittke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Borchmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens-Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Falk%22%2C%22lastName%22%3A%22Hiepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klemens%22%2C%22lastName%22%3A%22Ruprecht%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uta%22%2C%22lastName%22%3A%22Behrends%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carola%22%2C%22lastName%22%3A%22Meindl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans-Dieter%22%2C%22lastName%22%3A%22Volk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulf%22%2C%22lastName%22%3A%22Reimer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carmen%22%2C%22lastName%22%3A%22Scheibenbogen%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Epstein-Barr-Virus%20%28EBV%29%20plays%20an%20important%20role%20as%20trigger%20or%20cofactor%20for%20various%20autoimmune%20diseases.%20In%20a%20subset%20of%20patients%20with%20Chronic%20Fatigue%20Syndrome%20%28CFS%29%20disease%20starts%20with%20infectious%20mononucleosis%20as%20late%20primary%20EBV-infection%2C%20whereby%20altered%20levels%20of%20EBV-specific%20antibodies%20can%20be%20observed%20in%20another%20subset%20of%20patients.%5CnMETHODS%3A%20We%20performed%20a%20comprehensive%20mapping%20of%20the%20IgG%20response%20against%20EBV%20comparing%2050%20healthy%20controls%20with%2092%20CFS%20patients%20using%20a%20microarray%20platform.%20Patients%20with%20multiple%20sclerosis%20%28MS%29%2C%20systemic%20lupus%20erythematosus%20%28SLE%29%20and%20cancer-related%20fatigue%20served%20as%20controls.%203054%20overlapping%20peptides%20were%20synthesised%20as%2015-mers%20from%2014%20different%20EBV%20proteins.%20Array%20data%20was%20validated%20by%20ELISA%20for%20selected%20peptides.%20Prevalence%20of%20EBV%20serotypes%20was%20determined%20by%20qPCR%20from%20throat%20washing%20samples.%5CnRESULTS%3A%20EBV%20type%201%20infections%20were%20found%20in%20patients%20and%20controls.%20EBV%20seroarray%20profiles%20between%20healthy%20controls%20and%20CFS%20were%20less%20divergent%20than%20that%20observed%20for%20MS%20or%20SLE.%20We%20found%20significantly%20enhanced%20IgG%20responses%20to%20several%20EBNA-6%20peptides%20containing%20a%20repeat%20sequence%20in%20CFS%20patients%20compared%20to%20controls.%20EBNA-6%20peptide%20IgG%20responses%20correlated%20well%20with%20EBNA-6%20protein%20responses.%20The%20EBNA-6%20repeat%20region%20showed%20sequence%20homologies%20to%20various%20human%20proteins.%5CnCONCLUSION%3A%20Patients%20with%20CFS%20had%20a%20quite%20similar%20EBV%20IgG%20antibody%20response%20pattern%20as%20healthy%20controls.%20Enhanced%20IgG%20reactivity%20against%20an%20EBNA-6%20repeat%20sequence%20and%20against%20EBNA-6%20protein%20is%20found%20in%20CFS%20patients.%20Homologous%20sequences%20of%20various%20human%20proteins%20with%20this%20EBNA-6%20repeat%20sequence%20might%20be%20potential%20targets%20for%20antigenic%20mimicry.%22%2C%22date%22%3A%222017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0179124%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%226DTIS6M4%22%2C%22J987ELTY%22%2C%22W637CI9M%22%2C%228B2HH96K%22%5D%2C%22dateModified%22%3A%222024-05-15T14%3A23%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22CVLJPASE%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kreissl%20et%20al.%22%2C%22parsedDate%22%3A%222016-10-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKreissl%2C%20Stefanie%2C%20Horst%20Mueller%2C%20Helen%20Goergen%2C%20Axel%20Mayer%2C%20Corinne%20Brillant%2C%20Karolin%20Behringer%2C%20Teresa%20Veronika%20Halbsguth%2C%20et%20al.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1470204516300936%26%23039%3B%26gt%3BCancer-related%20fatigue%20in%20patients%20with%20and%20survivors%20of%20Hodgkin%26%23039%3Bs%20lymphoma%3A%20a%20longitudinal%20study%20of%20the%20German%20Hodgkin%20Study%20Group%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BThe%20Lancet%20Oncology%26lt%3B%5C%2Fi%26gt%3B%2017%2C%20no.%2010%20%28October%201%2C%202016%29%3A%201453%5Cu201362.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1470-2045%2816%2930093-6.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cancer-related%20fatigue%20in%20patients%20with%20and%20survivors%20of%20Hodgkin%27s%20lymphoma%3A%20a%20longitudinal%20study%20of%20the%20German%20Hodgkin%20Study%20Group%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefanie%22%2C%22lastName%22%3A%22Kreissl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Horst%22%2C%22lastName%22%3A%22Mueller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Goergen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Axel%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinne%22%2C%22lastName%22%3A%22Brillant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karolin%22%2C%22lastName%22%3A%22Behringer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Teresa%20Veronika%22%2C%22lastName%22%3A%22Halbsguth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felicitas%22%2C%22lastName%22%3A%22Hitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Soekler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oluwatoyin%22%2C%22lastName%22%3A%22Shonukan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22Rueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans-Henning%22%2C%22lastName%22%3A%22Flechtner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Fuchs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Volker%22%2C%22lastName%22%3A%22Diehl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Engert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Borchmann%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnPatients%20with%20Hodgkin%26%23039%3Bs%20lymphoma%20might%20have%20persistent%20fatigue%20even%20years%20after%20treatment.%20However%2C%20knowledge%20of%20the%20development%20of%20fatigue%20persisting%20long%20after%20completion%20of%20treatment%20is%20limited.%20Therefore%2C%20we%20did%20a%20detailed%20analysis%20of%20fatigue%20in%20our%20first-line%20clinical%20trials%20for%20early-stage%20favourable%20%28HD13%20trial%29%2C%20early-stage%20unfavourable%20%28HD14%20trial%29%2C%20and%20advanced-stage%20%28HD15%20trial%29%20Hodgkin%26%23039%3Bs%20lymphoma.%20Beyond%20the%20description%20of%20fatigue%20from%20diagnosis%20up%20to%205%20years%20after%20treatment%2C%20we%20aimed%20to%20assess%20any%20effect%20of%20patient%20characteristics%2C%20disease%20characteristics%2C%20or%20treatment%20characteristics%20on%20persistent%20fatigue.%5CnMethods%5CnIn%20this%20longitudinal%20study%2C%20we%20included%20patients%20with%20early-stage%20favourable%2C%20early-stage%20unfavourable%2C%20and%20advanced-stage%20Hodgkin%26%23039%3Bs%20lymphoma%20from%20the%20HD13%2C%20HD14%2C%20and%20HD15%20trials%2C%20respectively%2C%20aged%20between%2018%20and%2060%20years.%20Eligible%20patients%20for%20these%20trials%20had%20newly%20diagnosed%2C%20histologically%20proven%20Hodgkin%26%23039%3Bs%20lymphoma%2C%20an%20Eastern%20Cooperative%20Oncology%20Group%20performance%20status%20of%202%20or%20lower%2C%20HIV%20negativity%2C%20and%20absence%20of%20comorbidity%20disallowing%20protocol%20treatment.%20We%20used%20the%20fatigue%20scale%20of%20the%20European%20Organisation%20for%20Research%20and%20Treatment%20of%20Cancer%20%28EORTC%29%20QLQ-C30%20questionnaire%20to%20assess%20fatigue%20from%20diagnosis%20up%20to%205%20years%20after%20the%20end%20of%20treatment.%20The%20primary%20outcomes%20of%20interest%20in%20this%20study%20were%20fatigue%20scores%20in%20the%20second%20and%20fifth%20year%20after%20end%20of%20treatment.%20We%20estimated%20the%20effect%20of%20different%20disease%2C%20patient%2C%20and%20treatment%20characteristics%20on%20fatigue%20with%20multiple%20regression%20analyses%20and%20identified%20fatigue%20trajectories%20with%20growth%20mixture%20models.%20The%20regression%20analyses%20and%20growth%20mixture%20models%20used%20robust%20and%20full%20information%20maximum%20likelihood%20estimates%20to%20account%20for%20missing%20data.%20The%20HD13%2C%20HD14%2C%20and%20HD15%20trials%20are%20registered%20as%20international%20standard%20randomised%20controlled%20trials%2C%20ISRCTN63474366%2C%20ISRCTN04761296%2C%20and%20ISRCTN32443041%2C%20respectively.%5CnFindings%5CnThe%20HD13%20trial%20enrolled%20patients%20with%20early-stage%20favourable%20disease%20from%20Jan%2028%2C%202003%2C%20to%20Sept%2030%2C%202009%3B%20the%20HD14%20trial%20enrolled%20patients%20with%20early-stage%20unfavourable%20disease%20from%20Jan%2028%2C%202003%2C%20to%20Dec%2023%2C%202009%3B%20and%20the%20HD15%20trial%20enrolled%20patients%20with%20advanced-stage%20disease%20from%20Jan%2028%2C%202003%2C%20to%20April%2018%2C%202008.%205306%20patients%20were%20enrolled%20in%20these%20trials.%20We%20analysed%204215%20patients%20with%20any%20valid%20fatigue%20assessment%20up%20to%205%20years%20after%20the%20end%20of%20treatment.%20Patients%20with%20higher%20tumour%20burden%20at%20diagnosis%20had%20more%20fatigue%20at%20baseline%20%28mean%20fatigue%20score%20in%20HD13%3A%2030%5Cu00b78%20%5BSD%2028%5Cu00b70%5D%3B%20in%20HD14%3A%2039%5Cu00b78%20%5B29%5Cu00b74%5D%2C%20and%20in%20HD15%3A%2049%5Cu00b70%20%5B30%5Cu00b72%5D%29.%20Fatigue%20scores%20%28FA%29%20in%20the%20second%20year%20after%20the%20end%20of%20treatment%20were%2028%5Cu00b75%20%2824%5Cu00b77%29%20in%20HD13%2C%2028%5Cu00b78%20%2824%5Cu00b74%29%20in%20HD14%2C%20and%2030%5Cu00b77%20%2824%5Cu00b74%29%20in%20HD15%3B%20in%20the%20fifth%20year%20after%20the%20end%20of%20treatment%20FA%20was%2030%5Cu00b78%20%2826%5Cu00b70%29%20in%20HD13%2C%2027%5Cu00b71%20%2824%5Cu00b78%29%20in%20HD14%2C%20and%2028%5Cu00b72%20%2824%5Cu00b79%29%20in%20HD15.%20Predictors%20of%20fatigue%20in%20the%20second%20and%20fifth%20year%20after%20end%20of%20treatment%20were%20baseline%20fatigue%20%28p%26lt%3B0%5Cu00b70001%29%20and%20age%20as%20a%20continuous%20variable%20%28p%26lt%3B0%5Cu00b70001%29.%20In%20addition%20to%20preceding%20fatigue%20and%20age%2C%20patient%20sex%20and%20Hodgkin%26%23039%3Bs%20lymphoma%20specific%20risk%20factors%20at%20baseline%20did%20not%20consistently%20and%20significantly%20improve%20the%20prognosis%20of%20fatigue%20in%20the%20first%2C%20second%2C%20and%20fifth%20year%20after%20end%20of%20treatment.%20There%20was%20no%20significant%20effect%20of%20treatment%20on%20fatigue%20scores%20in%20the%20second%20and%20fifth%20year%20after%20treatment.%5CnInterpretation%5CnOur%20findings%20show%20a%20high%20incidence%20of%20severe%20acute%20and%20persistent%20fatigue%20in%20Hodgkin%26%23039%3Bs%20lymphoma%20survivors%2C%20which%20is%20largely%20independent%20of%20tumour%20stage%20and%20treatment.%20Our%20results%20contribute%20to%20a%20better%20understanding%20of%20fatigue%20in%20patients%20with%20Hodgkin%26%23039%3Bs%20lymphoma%20and%20Hodgkin%26%23039%3Bs%20lymphoma%20survivors%20and%20could%20inform%20development%20of%20urgently%20needed%20intervention%20strategies.%5CnFunding%5CnDeutsche%20Krebshilfe.%22%2C%22date%22%3A%22October%201%2C%202016%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2FS1470-2045%2816%2930093-6%22%2C%22ISSN%22%3A%221470-2045%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1470204516300936%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22W637CI9M%22%5D%2C%22dateModified%22%3A%222024-05-15T13%3A43%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22EQJMYMTK%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Behringer%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBehringer%2C%20Karolin%2C%20Helen%20Goergen%2C%20Horst%20M%26%23xFC%3Bller%2C%20Indra%20Thielen%2C%20Corinne%20Brillant%2C%20Stefanie%20Kreissl%2C%20Teresa%20Veronika%20Halbsguth%2C%20et%20al.%20%26%23x201C%3BCancer-Related%20Fatigue%20in%20Patients%20With%20and%20Survivors%20of%20Hodgkin%20Lymphoma%3A%20The%20Impact%20on%20Treatment%20Outcome%20and%20Social%20Reintegration.%26%23x201D%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Clinical%20Oncology%3A%20Official%20Journal%20of%20the%20American%20Society%20of%20Clinical%20Oncology%26lt%3B%5C%2Fi%26gt%3B%2034%2C%20no.%2036%20%2820%202016%29%3A%204329%26%23x2013%3B37.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1200%5C%2FJCO.2016.67.7450%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1200%5C%2FJCO.2016.67.7450%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cancer-Related%20Fatigue%20in%20Patients%20With%20and%20Survivors%20of%20Hodgkin%20Lymphoma%3A%20The%20Impact%20on%20Treatment%20Outcome%20and%20Social%20Reintegration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karolin%22%2C%22lastName%22%3A%22Behringer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22Goergen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Horst%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Indra%22%2C%22lastName%22%3A%22Thielen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinne%22%2C%22lastName%22%3A%22Brillant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefanie%22%2C%22lastName%22%3A%22Kreissl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Teresa%20Veronika%22%2C%22lastName%22%3A%22Halbsguth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Meissner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Greil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Moosmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oluwatoyin%22%2C%22lastName%22%3A%22Shonukan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22Rueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans-Henning%22%2C%22lastName%22%3A%22Flechtner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Fuchs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Volker%22%2C%22lastName%22%3A%22Diehl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Engert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Borchmann%22%7D%5D%2C%22abstractNote%22%3A%22Purpose%20Cancer-related%20fatigue%20occurs%20frequently%20in%20patients%20with%20Hodgkin%20lymphoma%20%28HL%29%20and%20has%20a%20major%20impact%20on%20their%20quality%20of%20life.%20We%20hypothesized%20that%20severe%20fatigue%20%28sFA%29%20might%20have%20an%20impact%20on%20patients%26%23039%3B%20treatment%20outcome%20and%20social%20reintegration.%20Methods%20Of%205%2C306%20patients%20enrolled%20in%20the%20German%20Hodgkin%20Study%20Group%26%23039%3Bs%20fifth%20generation%20of%20clinical%20trials%20in%20HL%20%28HD13%2C%20HD14%2C%20and%20HD15%3B%20nonqualified%20and%20older%20%5B%26gt%3B%2060%20years%5D%20patients%20excluded%29%2C%204%2C529%20provided%20data%20on%20health-related%20quality%20of%20life.%20We%20describe%20sFA%20%28defined%20as%20a%20score%20%5Cu2265%2050%20on%20the%200%20to%20100%20scale%20from%20the%20European%20Organisation%20for%20Research%20and%20Treatment%20of%20Cancer%20Quality%20of%20Life%20Questionnaire%20Core%2030%29%20before%20and%20up%20to%209%20years%20after%20therapy%20and%20analyze%20its%20impact%20on%20treatment%20outcome%20and%20social%20reintegration.%20Results%20The%20proportion%20of%20patients%20reporting%20sFA%20was%2037%25%20at%20baseline%20and%20ranged%20from%2020%25%20to%2024%25%20during%20follow-up.%20Baseline%20sFA%20was%20associated%20with%20significantly%20impaired%20progression-free%20survival%20and%20a%20trend%20to%20impaired%20overall%20survival%2C%20which%20can%20be%20overcome%20in%20patients%20receiving%20highly%20effective%20HL%20therapies%20as%20applied%20in%20our%20fifth-generation%20trials.%20Our%20analysis%20revealed%20a%20significant%20negative%20association%20of%20sFA%20and%20employment%20in%20survivors%3A%205%20years%20after%20therapy%2C%2051%25%20and%2063%25%20of%20female%20and%20male%20survivors%2C%20respectively%2C%20with%20sFA%20were%20working%20or%20in%20professional%20education%2C%20compared%20with%2078%25%20and%2090%25%20without%20sFA%2C%20respectively%20%28%20P%20%26lt%3B%20.001%20adjusted%20for%20age%2C%20sex%2C%20stage%2C%20baseline%20employment%20status%2C%20and%20treatment%20outcome%29.%20sFA%20was%20also%20associated%20with%20financial%20problems%20and%20the%20number%20of%20visits%20to%20a%20general%20practitioner%20and%20medical%20specialists.%20Conclusion%20sFA%20is%20an%20important%20factor%20preventing%20survivors%20from%20social%20reintegration%20during%20follow-up.%20This%20observation%20underscores%20the%20need%20to%20address%20fatigue%20as%20a%20significant%20diagnosis%20when%20treating%20patients%20with%20and%20survivors%20of%20cancer.%22%2C%22date%22%3A%2212%2020%2C%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1200%5C%2FJCO.2016.67.7450%22%2C%22ISSN%22%3A%221527-7755%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22W637CI9M%22%2C%228B2HH96K%22%2C%22P9CVNWVH%22%2C%22N24UXA6K%22%5D%2C%22dateModified%22%3A%222024-06-06T07%3A14%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22B7ESLT6R%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fischer%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFischer%2C%20Irene%2C%20Carola%20Riedner%2C%20Peter%20Bojko%2C%20Manfred%20E.%20Heim%2C%20Jens%20U.%20R%26%23xFC%3Bffer%2C%20Markus%20Besseler%2C%20Pia%20Heu%26%23xDF%3Bner%2C%20et%20al.%20%26%23x201C%3BConsultation%20Program%20for%20Patients%20with%20Cancer-Related%20Fatigue%3A%20A%20Systematic%20Evaluation%20of%20the%20Experiences%20of%20the%20Bavarian%20Cancer%20Society.%26%23x201D%3B%20%26lt%3Bi%26gt%3BOncology%20Research%20and%20Treatment%26lt%3B%5C%2Fi%26gt%3B%2039%2C%20no.%2010%20%282016%29%3A%20646%26%23x2013%3B51.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000448907%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000448907%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Consultation%20Program%20for%20Patients%20with%20Cancer-Related%20Fatigue%3A%20A%20Systematic%20Evaluation%20of%20the%20Experiences%20of%20the%20Bavarian%20Cancer%20Society%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irene%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carola%22%2C%22lastName%22%3A%22Riedner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Bojko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manfred%20E.%22%2C%22lastName%22%3A%22Heim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Markus%22%2C%22lastName%22%3A%22Besseler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pia%22%2C%22lastName%22%3A%22Heu%5Cu00dfner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valeria%22%2C%22lastName%22%3A%22Milani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nina%22%2C%22lastName%22%3A%22Rinas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%5Cu00fcnter%22%2C%22lastName%22%3A%22Schlimok%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erhard%22%2C%22lastName%22%3A%22Schneider%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Koller%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1159%5C%2F000448907%22%2C%22ISSN%22%3A%222296-5262%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22W637CI9M%22%2C%223ASQKG6E%22%2C%22P9CVNWVH%22%2C%22N24UXA6K%22%5D%2C%22dateModified%22%3A%222024-06-05T08%3A56%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22GITL4EK4%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%20and%20Adamietz%22%2C%22parsedDate%22%3A%222013-04-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%5Cu00fcffer%2C%20J.U.%2C%20and%20I.A.%20Adamietz.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00761-012-2408-6%26%23039%3B%26gt%3BFatigue%20%5Cu2013%20Tumorersch%5Cu00f6pfung%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BDer%20Onkologe%26lt%3B%5C%2Fi%26gt%3B%2019%2C%20no.%204%20%28April%201%2C%202013%29%3A%20279%5Cu201389.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Fatigue%20%5Cu2013%20Tumorersch%5Cu00f6pfung%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.A.%22%2C%22lastName%22%3A%22Adamietz%22%7D%5D%2C%22abstractNote%22%3A%22Obwohl%20die%20subjektive%20Todesbedrohung%20von%20Betroffenen%20und%20Nichtbetroffenen%20kaum%20abgenommen%20hat%2C%20%5Cu00fcberleben%20heute%20mehr%20als%20die%20H%5Cu00e4lfte%20aller%20Tumorpatienten%20ihre%20Erkrankung.%20Auch%20wenn%20die%20Anstrengungen%20zur%20Verbesserung%20der%20Therapieergebnisse%20nicht%20nachlassen%20d%5Cu00fcrfen%2C%20r%5Cu00fccken%20nun%20vermehrt%20Fragen%20zur%20Qualit%5Cu00e4t%20des%20%5Cu00dcberlebens%2C%20Quality%20of%20Survivorship%2C%20in%20den%20Fokus%20der%20Behandler.%20Dabei%20spielt%20die%20Tumorersch%5Cu00f6pfung%20als%20schwerwiegende%20Nebenwirkung%2C%20die%20mit%20einer%20Krebserkrankung%20einhergeht%2C%20eine%20zentrale%20Rolle.%22%2C%22date%22%3A%222013-04-01%22%2C%22language%22%3A%22de%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00761-012-2408-6%22%2C%22ISSN%22%3A%221433-0415%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00761-012-2408-6%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A29%3A34Z%22%7D%7D%2C%7B%22key%22%3A%2223ML89SF%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aapro%20et%20al.%22%2C%22parsedDate%22%3A%222012-07-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAapro%2C%20M.%2C%20J.%20R%5Cu00fcffer%2C%20and%20S.%20Fruehauf.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.geriatriconcology.net%5C%2Farticle%5C%2FS1879-4068%2812%2900042-2%5C%2Fabstract%26%23039%3B%26gt%3BHaematological%20support%2C%20fatigue%20and%20elderly%20patients%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Geriatric%20Oncology%26lt%3B%5C%2Fi%26gt%3B%203%2C%20no.%203%20%28July%201%2C%202012%29%3A%20246%5Cu201355.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jgo.2012.04.004.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Haematological%20support%2C%20fatigue%20and%20elderly%20patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Aapro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Fruehauf%22%7D%5D%2C%22abstractNote%22%3A%22%26lt%3Bh2%26gt%3BAbstract%26lt%3B%5C%2Fh2%26gt%3B%26lt%3Bp%26gt%3BAs%20the%20median%20age%20of%20the%20global%20population%20rises%2C%20the%20incidence%20of%20cancer%20is%20also%20set%20to%20increase%2C%20leading%20to%20a%20growing%20elderly%20population%20with%20cancer.%20Despite%20this%20trend%2C%20older%20patients%20have%20traditionally%20been%20under-represented%20in%20the%20majority%20of%20oncology%20trials.%20This%20is%20largely%20due%20to%20their%20heterogeneous%20nature%20and%20extended%20medical%20histories%20that%20have%20the%20potential%20to%20hinder%20treatment.%20Indeed%2C%20it%20is%20widely%20recommended%20that%20patients%26%23039%3B%20suitability%20for%20a%20given%20treatment%20should%20not%20be%20based%20on%20age%20alone%2C%20but%20rather%20by%20an%20assessment%20of%20physiological%20age%20on%20an%20individual%20basis.%20As%20evidence%20grows%20that%20existing%20therapies%2C%20such%20as%20chemotherapy%2C%20can%20be%20suitable%20for%20older%20patients%2C%20the%20management%20of%20these%20patients%20has%20become%20of%20increasing%20importance%20to%20oncologists.%20In%20particular%2C%20the%20management%20of%20haematological%20toxicities%20and%20their%20effects%20may%20be%20key%20to%20achieving%20optimal%20clinical%20outcomes%20among%20patients%20undergoing%20chemotherapy.%20Using%20two%20of%20the%20most%20common%20haematological%20toxicities%2C%20anaemia%20and%20neutropenia%2C%20as%20examples%2C%20we%20explore%20current%20therapies%20for%20elderly%20patients%20with%20cancer%2C%20and%20discuss%20the%20future%20management%20of%20this%20growing%20patient%20population.%26lt%3B%5C%2Fp%26gt%3B%22%2C%22date%22%3A%222012%5C%2F07%5C%2F01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jgo.2012.04.004%22%2C%22ISSN%22%3A%221879-4068%2C%201879-4076%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.geriatriconcology.net%5C%2Farticle%5C%2FS1879-4068%2812%2900042-2%5C%2Fabstract%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A32%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22TJ3CT5TV%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Horneber%20et%20al.%22%2C%22parsedDate%22%3A%222012-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHorneber%2C%20Markus%2C%20Irene%20Fischer%2C%20Fernando%20Dimeo%2C%20Jens%20Ulrich%20R%5Cu00fcffer%2C%20and%20Joachim%20Weis.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.aerzteblatt.de%5C%2Farchiv%5C%2F122868%5C%2FTumor-assoziierte-Fatigue%26%23039%3B%26gt%3BTumor-assoziierte%20Fatigue.%20Epidemiologie%2C%20Pathogenese%2C%20Diagnostik%20und%20Therapie%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BDeutsches%20Arzteblatt%20International%26lt%3B%5C%2Fi%26gt%3B%20109%2C%20no.%209%20%28March%202012%29%3A%20161%5Cu201371%3B%20quiz%20172.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3238%5C%2Farztebl.2012.0161.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tumor-assoziierte%20Fatigue.%20Epidemiologie%2C%20Pathogenese%2C%20Diagnostik%20und%20Therapie%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Markus%22%2C%22lastName%22%3A%22Horneber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irene%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Dimeo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joachim%22%2C%22lastName%22%3A%22Weis%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Many%20cancer%20patients%20suffer%20from%20cancer-related%20fatigue%20%28CRF%29%20both%20during%20and%20after%20their%20treatment.%20CRF%20can%20arise%20at%20any%20point%20in%20the%20course%20of%20the%20disease%20and%20can%20be%20either%20self-limited%20or%20persistent%2C%20sometimes%20for%20years.%20It%20gives%20rise%20to%20a%20vicious%20circle%20of%20impaired%20physical%20performance%2C%20avoidance%20of%20exertion%2C%20inactivity%2C%20inadequate%20physical%20recovery%2C%20helplessness%2C%20and%20depressed%20mood.%20Its%20hallmarks%20are%20tiredness%2C%20exhaustion%2C%20and%20lack%20of%20energy%3B%20it%20can%20impair%20performance%20so%20severely%20that%20the%20patient%20is%20unable%20to%20work.%20It%20is%20associated%20with%20increased%20mortality.%20Cancer%20patients%20are%20hardly%20ever%20systematically%20asked%20about%20the%20symptoms%20and%20signs%20of%20CRF.%20The%20stress%20and%20impairments%20that%20it%20produces%20are%20often%20inadequately%20appreciated%2C%20and%20the%20opportunities%20for%20treatment%20often%20neglected.%5CnMETHOD%3A%20Selective%20review%20of%20the%20pertinent%20literature%2C%20including%20published%20guidelines%20from%20Germany%20and%20abroad.%5CnRESULTS%3A%20The%20pathogenesis%20of%20CRF%20is%20complex%2C%20involving%20an%20interaction%20of%20somatic%2C%20emotional%2C%20cognitive%2C%20and%20psychosocial%20factors%2C%20with%20a%20highly%20variable%20pattern%20of%20clinical%20expression.%20Clinical%20history-taking%20plays%20a%20key%20role%20in%20diagnostic%20assessment.%20Depressive%20disorders%20must%20be%20considered%20in%20the%20differential%20diagnosis.%20Many%20randomized%20trials%20and%20meta-analyses%20have%20documented%20the%20efficacy%20of%20pharmacological%20and%20non-pharmacological%20treatments%20for%20CRF.%5CnCONCLUSION%3A%20Cancer-related%20fatigue%20is%20a%20serious%20problem%20that%20impairs%20patients%20physically%2C%20mentally%2C%20and%20socially.%20Physicians%20need%20to%20know%20how%20to%20recognize%20and%20treat%20it.%22%2C%22date%22%3A%22Mar%202012%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3238%5C%2Farztebl.2012.0161%22%2C%22ISSN%22%3A%221866-0452%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.aerzteblatt.de%5C%2Farchiv%5C%2F122868%5C%2FTumor-assoziierte-Fatigue%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22SPWXRLZV%22%2C%22QXIGN3AI%22%2C%22W637CI9M%22%2C%22P9CVNWVH%22%5D%2C%22dateModified%22%3A%222025-05-18T08%3A17%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22RL2PGGL8%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zimmer%20and%20R%5Cu00fcffer%22%2C%22parsedDate%22%3A%222012%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BZimmer%2C%20Philipp%2C%20and%20Jens%20Ulrich%20R%5Cu00fcffer.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-3-642-25066-8_7%26%23039%3B%26gt%3BFatigue-Syndrom%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20In%20%26lt%3Bi%26gt%3BSport%20und%20k%5Cu00f6rperliche%20Aktivit%5Cu00e4t%20in%20der%20Onkologie%26lt%3B%5C%2Fi%26gt%3B%2C%20edited%20by%20Freerk%20T.%20Baumann%2C%20Elke%20J%5Cu00e4ger%2C%20and%20Wilhelm%20Bloch%2C%2069%5Cu201378.%20Berlin%2C%20Heidelberg%3A%20Springer%2C%202012.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Fatigue-Syndrom%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philipp%22%2C%22lastName%22%3A%22Zimmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Freerk%20T.%22%2C%22lastName%22%3A%22Baumann%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Elke%22%2C%22lastName%22%3A%22J%5Cu00e4ger%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Wilhelm%22%2C%22lastName%22%3A%22Bloch%22%7D%5D%2C%22abstractNote%22%3A%22Die%20im%20englischen%20Sprachraum%20gebr%5Cu00e4uchliche%20Bezeichnung%20%5Cu201ecancer%20related%20fatigue%5Cu201c%20%28CRF%29%20ist%20weitaus%20zutreffender%20als%20die%20fr%5Cu00fcher%20im%20deutschen%20Sprachraum%20genutzten%20Begriffe%20%5Cu201eM%5Cu00fcdigkeit%5Cu201c%20und%20%5Cu201eErsch%5Cu00f6pfung%5Cu201c.%20Definitionsgem%5Cu00e4%5Cu00df%20ist%20das%20allgemeine%20Fatigue-Syndrom%20von%20dem%20Krebs-%20bzw.%20dem%20Krebstherapie-assoziierten%20Fatigue-Syndrom%20abzugrenzen%2C%20wenngleich%20Parallelen%20zu%20physischer%20und%20mentaler%20Ersch%5Cu00f6pfungsauspr%5Cu00e4gung%20zu%20erkennen%20sind.%20Die%20folgenden%20Ausf%5Cu00fchrungen%20beziehen%20sich%20auf%20die%20krebsinduzierte%20Ersch%5Cu00f6pfung%20und%20werden%20daher%20mit%20der%20Abk%5Cu00fcrzung%20CRF%20benannt.%22%2C%22bookTitle%22%3A%22Sport%20und%20k%5Cu00f6rperliche%20Aktivit%5Cu00e4t%20in%20der%20Onkologie%22%2C%22date%22%3A%222012%22%2C%22language%22%3A%22de%22%2C%22ISBN%22%3A%22978-3-642-25066-8%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-3-642-25066-8_7%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A56%3A08Z%22%7D%7D%2C%7B%22key%22%3A%2295E36WDK%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Armbrecht%20et%20al.%22%2C%22parsedDate%22%3A%222011%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BArmbrecht%2C%20Axel%2C%20Andreas%20Gr%5Cu00f6schel%2C%20Christoph%20P%5Cu00f6ttgen%2C%20Martin%20Reck%2C%20Jens%20Ulrich%20R%5Cu00fcffer%2C%20Ulf%20Seifart%2C%20Cornelia%20M.%20Ulrich%2C%20and%20Hauke%20Winter.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.karger.com%5C%2FArticle%5C%2FFullText%5C%2F328515%26%23039%3B%26gt%3BNachsorge%2C%20Komplikationen%20und%20deren%20Therapie%20bei%20der%20operativen%2C%20strahlentherapeutischen%20und%20medikament%5Cu00f6sen%20Therapie%20des%20Lungenkarzinoms%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BOncology%20Research%20and%20Treatment%26lt%3B%5C%2Fi%26gt%3B%2034%2C%20no.%20Suppl.%204%20%282011%29%3A%2011%5Cu201316.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000328515.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Nachsorge%2C%20Komplikationen%20und%20deren%20Therapie%20bei%20der%20operativen%2C%20strahlentherapeutischen%20und%20medikament%5Cu00f6sen%20Therapie%20des%20Lungenkarzinoms%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Axel%22%2C%22lastName%22%3A%22Armbrecht%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Gr%5Cu00f6schel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22P%5Cu00f6ttgen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Reck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulf%22%2C%22lastName%22%3A%22Seifart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cornelia%20M.%22%2C%22lastName%22%3A%22Ulrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hauke%22%2C%22lastName%22%3A%22Winter%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222011%22%2C%22language%22%3A%22german%22%2C%22DOI%22%3A%2210.1159%5C%2F000328515%22%2C%22ISSN%22%3A%222296-5270%2C%202296-5262%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.karger.com%5C%2FArticle%5C%2FFullText%5C%2F328515%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22W637CI9M%22%5D%2C%22dateModified%22%3A%222024-05-15T14%3A14%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22V79WQW6T%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%22%2C%22parsedDate%22%3A%222011%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%5Cu00fcffer%2C%20Jens-Ulrich.%20%26lt%3Bi%26gt%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fd-nb.info%5C%2F1018253467%26%23039%3B%26gt%3BGestern%20war%20ich%20noch%20einer%20von%20Euch%2C%20heute%20habe%20ich%20Krebs%3A%20ein%20Theaterst%5Cu00fcck%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fi%26gt%3B.%201.%20Aufl.%20K%5Cu00f6ln%3A%20Atp-Verl.%2C%20Gesundheit%2C%20Gesellschaft%2C%20Leben%2C%202011.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22book%22%2C%22title%22%3A%22Gestern%20war%20ich%20noch%20einer%20von%20Euch%2C%20heute%20habe%20ich%20Krebs%3A%20ein%20Theaterst%5Cu00fcck%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens-Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222011%22%2C%22language%22%3A%22ger%22%2C%22ISBN%22%3A%22978-3-943064-00-1%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fd-nb.info%5C%2F1018253467%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A55%3A53Z%22%7D%7D%2C%7B%22key%22%3A%2296QUDPEY%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kuhnt%20et%20al.%22%2C%22parsedDate%22%3A%222009%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKuhnt%2C%20Susanne%2C%20Jochen%20Ernst%2C%20Susanne%20Singer%2C%20Jens%20Ulrich%20R%5Cu00fcffer%2C%20Rolf-Dieter%20Kortmann%2C%20Jens-Uwe%20Stolzenburg%2C%20and%20Reinhold%20Schwarz.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.karger.com%5C%2FArticle%5C%2FFullText%5C%2F215943%26%23039%3B%26gt%3BFatigue%20in%20Cancer%20Survivors%20%5Cu2013%20Prevalence%20and%20Correlates%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BOncology%20Research%20and%20Treatment%26lt%3B%5C%2Fi%26gt%3B%2032%2C%20no.%206%20%282009%29%3A%20312%5Cu201317.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000215943.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Fatigue%20in%20Cancer%20Survivors%20%5Cu2013%20Prevalence%20and%20Correlates%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susanne%22%2C%22lastName%22%3A%22Kuhnt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jochen%22%2C%22lastName%22%3A%22Ernst%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susanne%22%2C%22lastName%22%3A%22Singer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens%20Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rolf-Dieter%22%2C%22lastName%22%3A%22Kortmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens-Uwe%22%2C%22lastName%22%3A%22Stolzenburg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reinhold%22%2C%22lastName%22%3A%22Schwarz%22%7D%5D%2C%22abstractNote%22%3A%22%26lt%3Bi%26gt%3BBackground%3A%20%26lt%3B%5C%2Fi%26gt%3BThe%20aim%20of%20this%20study%20was%20to%20determine%20the%20prevalence%20and%20influencing%20factors%20of%20fatigue%20in%20cancer%20survivors.%20%26lt%3Bi%26gt%3BPatients%20and%20Methods%3A%20%26lt%3B%5C%2Fi%26gt%3B646%20cancer%20survivors%20completed%20the%20Multidimensional%20Fatigue%20Inventory%20%28MFI-20%29%2C%20in%20addition%20to%20the%20Hospital%20Anxiety%20and%20Depression%20Scale%20%28HADS%29%2C%20the%20Quality%20Of%20Life%20questionnaire%20EORTC%20QLQ-C30%20%28European%20Organization%20for%20Research%20and%20Treatment%20of%20Cancer%20QLQ-C30%29%2C%20the%20subscale%20%5Cu2018social%20support%5Cu2019%20of%20the%20Functional%20Assessment%20of%20Cancer%20Therapy%20Scale%20%28FACT%29%2C%20the%20Perceived%20Adjustment%20to%20Chronic%20Illness%20Scale%20%28PACIS%29%2C%20and%20a%20questionnaire%20containing%20items%20on%20demographic%20and%20clinical%20data.%20%26lt%3Bi%26gt%3BResults%3A%20%26lt%3B%5C%2Fi%26gt%3B36%25%20of%20cancer%20survivors%20suffer%20from%20moderate%2C%2012%25%20from%20severe%20fatigue.%20Fatigue%20was%20significantly%20associated%20with%20depression%2C%20anxiety%2C%20sleep%20difficulties%2C%20adjustment%20to%20the%20illness%2C%20pain%2C%20dyspnoea%2C%20age%2C%20lacking%20social%20support%2C%20and%20sex.%20Other%20socio-demographic%2C%20cancer-related%2C%20and%20treatment-related%20factors%20had%20no%20influence%20on%20fatigue.%20%26lt%3Bi%26gt%3BConclusion%3A%20%26lt%3B%5C%2Fi%26gt%3BFatigue%20in%20cancer%20survivors%20is%20strongly%20linked%20to%20physical%20and%20psychological%20aspects.%22%2C%22date%22%3A%222009%22%2C%22language%22%3A%22english%22%2C%22DOI%22%3A%2210.1159%5C%2F000215943%22%2C%22ISSN%22%3A%222296-5270%2C%202296-5262%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.karger.com%5C%2FArticle%5C%2FFullText%5C%2F215943%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22SPWXRLZV%22%2C%22QXIGN3AI%22%2C%22W637CI9M%22%2C%22N24UXA6K%22%5D%2C%22dateModified%22%3A%222024-06-05T09%3A02%3A47Z%22%7D%7D%2C%7B%22key%22%3A%2288T5FB6Z%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%22%2C%22parsedDate%22%3A%222009%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%5Cu00fcffer%2C%20Jens-Ulrich.%20%26lt%3Bi%26gt%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fd-nb.info%5C%2F999111361%26%23039%3B%26gt%3BFatigue%3A%20Hilfe%20bei%20tumorbedingter%20Ersch%5Cu00f6pfung%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fi%26gt%3B.%20Gr%5Cu00fcn-gelbe%20Brosch%5Cu00fcrenreihe%2013.%20Zwickau%3A%20S%5Cu00e4chsische%20Krebsges%2C%202009.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22book%22%2C%22title%22%3A%22Fatigue%3A%20Hilfe%20bei%20tumorbedingter%20Ersch%5Cu00f6pfung%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens-Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222009%22%2C%22language%22%3A%22ger%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fd-nb.info%5C%2F999111361%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A55%3A40Z%22%7D%7D%2C%7B%22key%22%3A%226EDC73KS%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Borchmann%20et%20al.%22%2C%22parsedDate%22%3A%222006-02-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBorchmann%2C%20P.%2C%20K.%20Behringer%2C%20A.%20Josting%2C%20J.%20U.%20Rueffer%2C%20R.%20Schnell%2C%20V.%20Diehl%2C%20A.%20Engert%2C%20H.%20M.%20Kvasnicka%2C%20and%20J.%20Thiele.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00292-005-0811-0%26%23039%3B%26gt%3BSekund%5Cu00e4rneoplasien%20nach%20erfolgreicher%20Prim%5Cu00e4rtherapie%20des%20malignen%20Hodgkin-Lymphoms%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BDer%20Pathologe%26lt%3B%5C%2Fi%26gt%3B%2027%2C%20no.%201%20%28February%201%2C%202006%29%3A%2047%5Cu201352.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sekund%5Cu00e4rneoplasien%20nach%20erfolgreicher%20Prim%5Cu00e4rtherapie%20des%20malignen%20Hodgkin-Lymphoms%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Borchmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Behringer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Josting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20U.%22%2C%22lastName%22%3A%22Rueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Schnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Diehl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Engert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20M.%22%2C%22lastName%22%3A%22Kvasnicka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Thiele%22%7D%5D%2C%22abstractNote%22%3A%22Das%20maligne%20Hodgkin-Lymphom%20%28HL%29%20ist%20durch%20die%20fortschreitende%20Entwicklung%20der%20Behandlungsintensit%5Cu00e4t%20eine%20heilbare%20Erkrankung%20geworden.%20Allerdings%20kann%20dieses%20aggressive%20Vorgehen%2C%20das%20h%5Cu00e4ufig%20Strahlen-%20und%20Chemotherapie%20kombiniert%2C%20u.%5Cu00a0a.%20sekund%5Cu00e4re%20Neoplasien%20zur%20Folge%20haben.%22%2C%22date%22%3A%222006-02-01%22%2C%22language%22%3A%22de%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00292-005-0811-0%22%2C%22ISSN%22%3A%221432-1963%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00292-005-0811-0%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A53%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22NLUDXLPW%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%20and%20Flechtner%22%2C%22parsedDate%22%3A%222006-01-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%5Cu00fcffer%2C%20J.%20U.%2C%20and%20H.%20Flechtner.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00761-005-0992-4%26%23039%3B%26gt%3BFatigue%20%5Cu2014%20Diagnostik%2C%20klinische%20Implikationen%20und%20Therapie%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BDer%20Onkologe%26lt%3B%5C%2Fi%26gt%3B%2012%2C%20no.%201%20%28January%201%2C%202006%29%3A%2036%5Cu201340.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Fatigue%20%5Cu2014%20Diagnostik%2C%20klinische%20Implikationen%20und%20Therapie%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Flechtner%22%7D%5D%2C%22abstractNote%22%3A%22Tumorbedingte%20Fatigue%2C%20die%20bei%20fast%20allen%20Tumorpatienten%20unter%20Therapie%20auftritt%20und%20bei%20einem%20erheblichen%20Teil%20der%20Patienten%20auch%20Jahre%20nach%20erfolgreicher%20Therapie%20nachweisbar%20ist%2C%20hat%20erheblichen%20Einfluss%20auf%20die%20Lebensqualit%5Cu00e4t%20und%20scheint%20auch%20den%20Therapieverlauf%20zu%20beeinflussen.%20%5Cu00dcber%20die%20Ursachen%20des%20Tumor-Fatigue-Syndroms%20ist%20bisher%20nur%20wenig%20bekannt.%20Gerade%20f%5Cu00fcr%20die%20%5Cu00fcber%20Jahre%20anhaltende%20Erm%5Cu00fcdung%20besteht%20Aufkl%5Cu00e4rungsbedarf.%20Mittels%20der%20zurzeit%20zur%20Verf%5Cu00fcgung%20stehenden%20Fragebogeninstrumente%20kann%20das%20Vorliegen%20und%20der%20Verlauf%20einer%20tumorbedingten%20Fatigue%20gut%20erfasst%20werden.%20Die%20Behandlung%20umfasst%20neben%20der%20Korrektur%20zugrunde%20liegender%20Stoffwechselst%5Cu00f6rungen%20v.%5Cu00a0a.%20k%5Cu00f6rperliches%20Training%20und%20psychoonkologische%20Ma%5Cu00dfnahmen%20zur%20Verbesserung%20der%20Krankheitsbew%5Cu00e4ltigung.%20Allerdings%20bleiben%20viele%20Fragen%2C%20so%20auch%20die%20Rolle%20des%20Tumor-Fatigue-Syndroms%20f%5Cu00fcr%20die%20Berufsunf%5Cu00e4higkeit%20oder%20Berentung%20von%20Tumorpatienten%20offen%2C%20sodass%20im%20M%5Cu00e4rz%202002%20zur%20weiteren%20Aufkl%5Cu00e4rung%20dieser%20Zusammenh%5Cu00e4nge%20die%20Deutsche%20Fatigue%20Gesellschaft%20%28DFaG%29%20gegr%5Cu00fcndet%20wurde.%22%2C%22date%22%3A%222006-01-01%22%2C%22language%22%3A%22de%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00761-005-0992-4%22%2C%22ISSN%22%3A%221433-0415%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00761-005-0992-4%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A32%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22S4AE2F3B%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%20et%20al.%22%2C%22parsedDate%22%3A%222005-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%26%23xFC%3Bffer%2C%20J.%20U.%2C%20V.%20Ballova%2C%20J.%20Glossmann%2C%20M.%20Sieber%2C%20J.%20Franklin%2C%20L.%20Nogova%2C%20V.%20Diehl%2C%20A.%20Josting%2C%20and%20German%20Hodgkin%20Study%20Group.%20%26%23x201C%3BBEACOPP%20and%20COPP%5C%2FABVD%20as%20Salvage%20Treatment%20after%20Primary%20Extended%20Field%20Radiation%20Therapy%20of%20Early%20Stage%20Hodgkins%20Disease%20-%20Results%20of%20the%20German%20Hodgkin%20Study%20Group.%26%23x201D%3B%20%26lt%3Bi%26gt%3BLeukemia%20%26amp%3B%20Lymphoma%26lt%3B%5C%2Fi%26gt%3B%2046%2C%20no.%2011%20%28November%202005%29%3A%201561%26%23x2013%3B67.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F10428190500178167%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F10428190500178167%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22BEACOPP%20and%20COPP%5C%2FABVD%20as%20salvage%20treatment%20after%20primary%20extended%20field%20radiation%20therapy%20of%20early%20stage%20Hodgkins%20disease%20-%20results%20of%20the%20German%20Hodgkin%20Study%20Group%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Ballova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Glossmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Sieber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Franklin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Nogova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Diehl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Josting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22German%20Hodgkin%20Study%20Group%22%7D%5D%2C%22abstractNote%22%3A%22Patients%20with%20early%20stage%20favorable%20Hodgkin%26%23039%3Bs%20disease%20who%20relapse%20after%20extended%20field%20radiotherapy%20have%20satisfactory%20results.%20We%20retrospectively%20analysed%20patients%20with%20relapsed%20HD%20after%20initial%20radiation%20therapy%20alone%20to%20determine%20treatment%20outcome%20and%20prognostic%20factors.%20Nine-hundred%20and%20forty%20five%20patients%20in%20localized%20stages%20without%20risk%20factors%20received%20either%2040%20Gy%20extended%20field%20RT%20or%2030%20Gy%20EF%20RT%20followed%20by%20an%20additional%2010%20Gy%20to%20involved%20lymph%20node%20regions.%20107%20patients%20relapsed%20and%20received%20salvage%20therapy.%20Characteristics%20of%20the%20107%20patients%20at%20relapse%20were%20as%20follows%3A%20median%20age%20was%2034%20years%20%28range%2018--75%29%20with%20relapse%20occuring%20at%20a%20median%20of%2019%20months%20%28range%204--98%20months%29%2C%2031%25%20were%20female.%20The%20majority%20of%20patients%20%2893%25%29%20were%20treated%20with%20conventional%20chemotherapy.%20Sixty-nine%20percent%20were%20treated%20with%20COPP%5C%2FABVD%20like%20regimens%2C%2021%25%20with%20BEACOPP%2C%20and%203%25%20received%20various%20other%20regimens.%20Seven%20percent%20were%20treated%20with%20radiotherapy%20alone.%20Complete%20remission%20was%20achieved%20in%2087%25%20of%20all%20salvaged%20patients.%20The%20median%20follow-up%20after%20relapse%20was%2045%20months.%20FF2F%20%28freedom%20from%20second%20treatment%20failure%29%20and%20OS%20%28overall%20survival%29%20were%2081%25%20and%2089%25%2C%20respectively.%20In%20multivariate%20analysis%20age%20was%20the%20major%20prognostic%20factor%20for%20FF2F%20and%20OS%20%28p%26lt%3B0.0001%2C%20for%20both%29.%20Further%20independent%20prognostic%20factors%20were%20B%20symptoms%20%28p%3D0.05%29%20and%20salvage%20chemotherapy%20%28p%3D0.03%29%20for%20FF2F%2C%20and%20B%20symptoms%20%28p%3D0.03%29%20and%20extranodal%20involvement%20%28p%3D0.02%29%20for%20OS.%20The%20long-term%20outcome%20of%20patients%20relapsing%20after%20EF%20RT%20is%20excellent.%20Age%2C%20B%20symptoms%2C%20extranodal%20involvement%20and%20salvage%20chemotherapy%20were%20identified%20as%20prognostic%20factors%20for%20second%20relapse%20and%20survival.%22%2C%22date%22%3A%22Nov%202005%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F10428190500178167%22%2C%22ISSN%22%3A%221042-8194%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A55%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22KPAD6IEJ%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ballova%20et%20al.%22%2C%22parsedDate%22%3A%222005-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBallova%2C%20V.%2C%20J.-U.%20R%26%23xFC%3Bffer%2C%20H.%20Haverkamp%2C%20B.%20Pfistner%2C%20H.%20K.%20M%26%23xFC%3Bller-Hermelink%2C%20E.%20D%26%23xFC%3Bhmke%2C%20P.%20Worst%2C%20et%20al.%20%26%23x201C%3BA%20Prospectively%20Randomized%20Trial%20Carried%20out%20by%20the%20German%20Hodgkin%20Study%20Group%20%28GHSG%29%20for%20Elderly%20Patients%20with%20Advanced%20Hodgkin%26%23x2019%3Bs%20Disease%20Comparing%20BEACOPP%20Baseline%20and%20COPP-ABVD%20%28Study%20HD9elderly%29.%26%23x201D%3B%20%26lt%3Bi%26gt%3BAnnals%20of%20Oncology%3A%20Official%20Journal%20of%20the%20European%20Society%20for%20Medical%20Oncology%26lt%3B%5C%2Fi%26gt%3B%2016%2C%20no.%201%20%28January%202005%29%3A%20124%26%23x2013%3B31.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fannonc%5C%2Fmdi023%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fannonc%5C%2Fmdi023%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20prospectively%20randomized%20trial%20carried%20out%20by%20the%20German%20Hodgkin%20Study%20Group%20%28GHSG%29%20for%20elderly%20patients%20with%20advanced%20Hodgkin%27s%20disease%20comparing%20BEACOPP%20baseline%20and%20COPP-ABVD%20%28study%20HD9elderly%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Ballova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.-U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Haverkamp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Pfistner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20K.%22%2C%22lastName%22%3A%22M%5Cu00fcller-Hermelink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22D%5Cu00fchmke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Worst%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Wilhelmy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Naumann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Hentrich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20T.%22%2C%22lastName%22%3A%22Eich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Josting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22L%5Cu00f6ffler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Diehl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Engert%22%7D%5D%2C%22abstractNote%22%3A%22In%20contrast%20to%20younger%20patients%2C%20the%20prognosis%20of%20elderly%20patients%20with%20advanced%20Hodgkin%26%23039%3Bs%20disease%20%28HD%29%20has%20not%20improved%20substantially%20over%20the%20last%2020%20years.%20We%20thus%20carried%20out%20a%20prospectively%20randomized%20study%20%28HD9%28elderly%29%29%20to%20compare%20the%20BEACOPP%20regimen%20in%20this%20setting%20against%20standard%20COPP-ABVD.%20Between%20February%201993%20and%201998%2C%2075%20patients%20aged%2066-75%20years%20with%20newly%20diagnosed%20HD%20in%20advanced%20stages%20were%20recruited%20into%20the%20HD9%20trial%20as%20a%20separate%20stratum%20%28HD9%28elderly%29%29.%20Patients%20were%20assigned%20to%20eight%20alternating%20cycles%20of%20COPP%20and%20ABVD%20or%20eight%20cycles%20of%20BEACOPP%20in%20baseline%20doses.%20Radiotherapy%20was%20given%20to%20initial%20bulky%20or%20residual%20disease.%20In%20total%2C%2068%20of%2075%20registered%20patients%20were%20assessable%3A%2026%20were%20treated%20with%20COPP-ABVD%20and%2042%20with%20BEACOPP%20baseline.%20There%20were%20no%20significant%20differences%20between%20COPP-ABVD%20and%20BEACOPP%20in%20terms%20of%20complete%20remission%20%2876%25%29%2C%20overall%20survival%20%2850%25%29%20and%20freedom%20from%20treatment%20failure%20%28FFTF%29%20%2846%25%29%20at%205%20years.%20At%20a%20median%20follow-up%20of%2080%20months%2C%20a%20total%20of%2037%20patients%20died%3A%2014%5C%2F26%20patients%20%2854%25%29%20treated%20with%20COPP-ABVD%20and%2023%5C%2F42%20patients%20%2855%25%29%20with%20BEACOPP.%20Two%20patients%20%288%25%29%20treated%20with%20COPP-ABVD%20and%20nine%20patients%20%2821%25%29%20treated%20with%20BEACOPP%20died%20of%20acute%20toxicity.%20Hodgkin-specific%20FFTF%20at%205%20years%20was%2055%25%20after%20COPP-ABVD%20and%2074%25%20after%20BEACOPP%20%28P%3D0.13%29.%20Thus%2C%20there%20are%20no%20differences%20in%20survival%20between%20these%20regimens%20in%20elderly%20patients.%22%2C%22date%22%3A%22Jan%202005%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fannonc%5C%2Fmdi023%22%2C%22ISSN%22%3A%220923-7534%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A53%3A36Z%22%7D%7D%2C%7B%22key%22%3A%2239L3IJZL%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%22%2C%22parsedDate%22%3A%222003-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%26%23xFC%3Bffer%2C%20J.%20U.%20%26%23x201C%3BTumor-Related%20Fatigue%20-%20an%20Underestimated%20Problem.%26%23x201D%3B%20%26lt%3Bi%26gt%3BOnkologie%26lt%3B%5C%2Fi%26gt%3B%2026%2C%20no.%205%20%28October%202003%29%3A%20423%26%23x2013%3B24.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000074730%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000074730%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tumor-related%20fatigue%20-%20an%20underestimated%20problem%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222003-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1159%5C%2F000074730%22%2C%22ISSN%22%3A%220378-584X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22X7PUUBWP%22%2C%22W637CI9M%22%2C%22P9CVNWVH%22%5D%2C%22dateModified%22%3A%222024-05-16T08%3A08%3A16Z%22%7D%7D%2C%7B%22key%22%3A%224TNRBK83%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Proctor%20et%20al.%22%2C%22parsedDate%22%3A%222002%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BProctor%2C%20S.%20J.%2C%20J.%20U.%20Rueffer%2C%20B.%20Angus%2C%20K.%20Breuer%2C%20H.%20Flechtner%2C%20R.%20Jarrett%2C%20A.%20Levis%2C%20P.%20Taylor%2C%20and%20U.%20Tirelli.%20%26%23x201C%3BHodgkin%26%23x2019%3Bs%20Disease%20in%20the%20Elderly%3A%20Current%20Status%20and%20Future%20Directions.%26%23x201D%3B%20%26lt%3Bi%26gt%3BAnnals%20of%20Oncology%3A%20Official%20Journal%20of%20the%20European%20Society%20for%20Medical%20Oncology%26lt%3B%5C%2Fi%26gt%3B%2013%20Suppl%201%20%282002%29%3A%20133%26%23x2013%3B37.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fannonc%5C%2F13.s1.133%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fannonc%5C%2F13.s1.133%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hodgkin%27s%20disease%20in%20the%20elderly%3A%20current%20status%20and%20future%20directions%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20J.%22%2C%22lastName%22%3A%22Proctor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20U.%22%2C%22lastName%22%3A%22Rueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Angus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Breuer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Flechtner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Jarrett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Levis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Tirelli%22%7D%5D%2C%22abstractNote%22%3A%22In%20general%2C%20it%20was%20agreed%20that%20high%20rates%20of%20toxicities%20during%20treatment%20occur%20in%20the%20elderly%20and%20that%20there%20is%20a%20frequent%20occurrence%20of%20early%20relapse.%20It%20is%20clear%20that%20different%20combinations%20of%20effective%20therapies%20with%20lower%20toxicity%20are%20required.%20It%20was%20felt%2C%20however%2C%20that%20certainly%20in%20the%2060-70%20year%20age%20group%2C%20approaches%20should%20be%20vigorous%20to%20and%20the%20same%20diagnostic%20and%20staging%20procedures%20as%20in%20younger%20individuals%2C%20but%20with%20much%20closer%20monitoring%20of%20toxicity%20and%20response%20to%20treatment.%20It%20was%20felt%20that%20as%20part%20of%20the%20approach%2C%20liberal%20support%20with%20haemopoeitic%20growth%20factors%20%28G-CSF%29%20was%20necessary%20to%20reduce%20prolonged%20neutropenia.%20It%20is%20important%20to%20understand%20that%20age%20in%20general%20is%20not%20a%20contrary%20indication%20for%20aggressive%20treatment%20and%20that%20biologically%20younger%20patients%20under%20the%20age%20of%2065%20years%2C%20in%20good%20physical%20and%20mental%20condition%2C%20often%20should%20be%20given%20with%20stage-adapted%20treatment%2C%20analogous%20to%20conventional%20treatment%20protocols%20for%20the%20%26lt%3B60%20years%20age%20group.%20It%20was%20also%20considered%20that%2C%20in%20patients%20who%20clearly%20could%20not%20accept%20conventional%20treatment%2C%20study%20groups%20could%20begin%20to%20define%20the%20best%20palliative%20care%20for%20patients%20with%20pre-existing%20organ%20impairment%2C%20and%20that%20in%20all%20situations%20of%20assessment%2C%20whether%20in%20trial%20or%20not%2C%20there%20should%20be%20a%20detailed%20prospective%20assessment%20of%20quality%20of%20life%20parameters.%22%2C%22date%22%3A%222002%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fannonc%5C%2F13.s1.133%22%2C%22ISSN%22%3A%220923-7534%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A55%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22QU8P4FWX%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%20et%20al.%22%2C%22parsedDate%22%3A%222002%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%5Cu00fcffer%2C%20U.%2C%20M.%20Sieber%2C%20and%20V.%20Diehl.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-3-642-56391-1_26%26%23039%3B%26gt%3BMorbus%20Hodgkin%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20In%20%26lt%3Bi%26gt%3BGeriatrische%20Onkologie%26lt%3B%5C%2Fi%26gt%3B%2C%20edited%20by%20Klaus%20H%5Cu00f6ffken%2C%20Ulrich%20Wedding%2C%20and%20Gerald%20Kolb%2C%20499%5Cu2013509.%20Berlin%2C%20Heidelberg%3A%20Springer%2C%202002.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Morbus%20Hodgkin%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Sieber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Diehl%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Klaus%22%2C%22lastName%22%3A%22H%5Cu00f6ffken%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Ulrich%22%2C%22lastName%22%3A%22Wedding%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Gerald%22%2C%22lastName%22%3A%22Kolb%22%7D%5D%2C%22abstractNote%22%3A%22Der%20Morbus%20Hodgkin%20ist%20eine%20maligne%20Erkrankung%20des%20lymphatischen%20Systems.%20Die%20Inzidenz%20der%20Erkrankung%20wird%20in%20Deutschland%20mit%20ca.%20drei%20Erkrankungen%5C%2F100.000%5C%2FJahr%20angegeben.%20Es%20findet%20sich%20eine%20zweigipflige%20Altersverteilung%20mit%20einem%201.%20gr%5Cu00f6%5Cu00dferen%20Erkrankungsgipfel%20im%203.%20Lebensjahrzehnt%20und%20einem%202.%20kleineren%20um%20das%206.%20Lebensjahrzehnt.%20W%5Cu00e4hrend%20um%20das%203.%20Lebensjahrzehnt%20die%20Geschlechter%20in%20gleichem%20Ma%5Cu00dfe%20betroffen%20sind%2C%20erkranken%20im%20h%5Cu00f6heren%20Alter%20h%5Cu00e4ufiger%20M%5Cu00e4nner.%20Unklar%20ist%2C%20ob%20das%20biologische%20und%20klinische%20Verhalten%20der%20Erkrankung%20in%20h%5Cu00f6herem%20Lebensalter%20anders%20ist.%20Dass%20die%20Erkrankung%20im%20h%5Cu00f6heren%20Lebensalter%20mit%20einer%20ung%5Cu00fcstigeren%20Histologie%20sowie%20einer%20schlechteren%20Prognose%20vergesellschaftet%20ist%20steht%20dagegen%20fest.%22%2C%22bookTitle%22%3A%22Geriatrische%20Onkologie%22%2C%22date%22%3A%222002%22%2C%22language%22%3A%22de%22%2C%22ISBN%22%3A%22978-3-642-56391-1%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2F978-3-642-56391-1_26%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%222JLBQKWD%22%2C%22W637CI9M%22%2C%22P9CVNWVH%22%5D%2C%22dateModified%22%3A%222024-05-16T16%3A07%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22B766GE6P%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rueffer%20et%20al.%22%2C%22parsedDate%22%3A%222001-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRueffer%2C%20U.%2C%20K.%20Breuer%2C%20A.%20Josting%2C%20B.%20Lathan%2C%20M.%20Sieber%2C%20O.%20Manzke%2C%20F.%20J.%20Grotenhermen%2C%20et%20al.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fpubmed.ncbi.nlm.nih.gov%5C%2F11697845%5C%2F%26%23039%3B%26gt%3BMale%20gonadal%20dysfunction%20in%20patients%20with%20Hodgkin%26%23039%3Bs%20disease%20prior%20to%20treatment%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BAnnals%20of%20Oncology%3A%20Official%20Journal%20of%20the%20European%20Society%20for%20Medical%20Oncology%26lt%3B%5C%2Fi%26gt%3B%2012%2C%20no.%209%20%28September%202001%29%3A%201307%5Cu201311.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1023%5C%2Fa%3A1012464703805.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Male%20gonadal%20dysfunction%20in%20patients%20with%20Hodgkin%27s%20disease%20prior%20to%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Rueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Breuer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Josting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Lathan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Sieber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Manzke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20J.%22%2C%22lastName%22%3A%22Grotenhermen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Tesch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Bredenfeld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Koch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Nisters-Backes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Wolf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Engert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Diehl%22%7D%5D%2C%22abstractNote%22%3A%22Infertility%20after%20treatment%20of%20patients%20with%20Hodgkin%26%23039%3Bs%20disease%20%28HD%29%20is%20considered%20as%20a%20side%20effect%20of%20alkylating%20agent%20containing%20chemotherapy%20regimens.%20To%20investigate%20whether%20gonadal%20failure%20is%20related%20primarily%20to%20the%20toxic%20effect%20of%20chemotherapy%20or%20rather%20to%20the%20disease%20itself%2C%20we%20investigated%20the%20fertility%20status%20before%20the%20onset%20of%20treatment.%5CnPATIENTS%20AND%20METHODS%3A%20Semen%20quality%20and%20hormonal%20status%20were%20evaluated%20in%20158%20patients%20with%20first%20diagnosis%20of%20HD%20enrolled%20into%20trials%20of%20the%20German%20Hodgkin%20Lymphoma%20Study%20Group%20%28GHSG%29.%20The%20median%20age%20of%20the%20patients%20was%2028%20years%20%28range%2016-52%29.%20Twenty%20patients%20%2813%25%29%20were%20classified%20as%20early%20stage%20HD%2C%2063%20patients%20%2840%25%29%20as%20intermediate%20stage%2C%20and%2075%20patients%20%2847%25%29%29%20as%20advanced%20stage%20according%20GHSG%20grading.%20Sixty-seven%20patients%20%2842%25%29%20showed%20systemic%20symptoms.%20Semen%20analysis%20was%20performed%20according%20to%20WHO%20guidelines.%20Follicle-stimulating%20hormone%20%28FSH%29%20and%20luteinising%20hormone%20%28LH%29%20plasma%20levels%20were%20measured%20by%20specific%20double-antibody%20radio-immune-assay%20%28RIA%29%20methods.%5CnRESULTS%3A%20Prior%20to%20treatment%2C%20severe%20damage%20of%20fertility%2C%20i.e..%20azoospermia%20and%20oligoasthenoteratospermia%20%28OAT-syndrome%29%20was%20found%20in%2013%20%288%25%29%20and%2020%20patients%20%2813%25%29%2C%20respectively.%20Thirty-eight%20patients%20%2824%25%29%20had%20single%2C%20i.e.%2C%20oligo-%28O%29%2C%20astheno-%28A%29%20or%20teratospermia-%28T%29%2C%20and%2040%20patients%20%2826%25%29%20showed%20combined%20damages%2C%20i.e.%2C%20OA%2C%20OT%20or%20AT.%20In%2047%20patients%20%2830%25%29%20a%20normal%20sperm%20count%20was%20found.%20Thus%2C%20III%20patients%20%2870%25%29%20showed%20semen%20abnormalities%20before%20the%20onset%20of%20treatment.%20In%20a%20multivariate%20analysis%20elevated%20ESR%20%28P%20%26lt%3B%200.003%29%20and%20advanced%20stage%20of%20disease%20%28P%20%26lt%3B%200.01%29%20could%20be%20distinguished%20as%20prognostic%20factors%20for%20severe%20damage%20of%20fertility.%20No%20correlation%20was%20found%20between%20pre-therapeutic%20gonadotropine%20levels%20and%20fertility%20status.%5CnCONCLUSION%3A%20Patients%20with%20HD%20have%20an%20increased%20risk%20for%20inadequate%20semen%20quality%20even%20prior%20to%20treatment.%20Infertility%20is%20more%20frequent%20in%20patients%20with%20elevated%20ESR%20and%20advanced%20stage%20of%20disease.%20This%20association%20demonstrates%20the%20predominant%20influence%20of%20the%20disease%20on%20fertility.%20Assuming%20HD%20is%20the%20major%20initial%20cause%20for%20infertility%20efforts%20should%20be%20made%20to%20identify%20new%20non-gonadal%20toxic%20chemotherapies%20to%20be%20able%20to%20regain%20fertility%20after%20effective%20therapy.%20Further%20investigations%20have%20to%20be%20performed%20to%20clarify%20mechanisms%20inducing%20fertility%20defects%20in%20patients%20with%20HD.%22%2C%22date%22%3A%222001-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1023%5C%2Fa%3A1012464703805%22%2C%22ISSN%22%3A%220923-7534%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpubmed.ncbi.nlm.nih.gov%5C%2F11697845%5C%2F%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%2C%22SPWXRLZV%22%2C%22W637CI9M%22%5D%2C%22dateModified%22%3A%222025-05-18T08%3A08%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22M8R3KX8U%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rueffer%20et%20al.%22%2C%22parsedDate%22%3A%222001-04-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRueffer%2C%20U.%2C%20A.%20Josting%2C%20J.%20Franklin%2C%20M.%20May%2C%20M.%20Sieber%2C%20K.%20Breuer%2C%20A.%20Engert%2C%20V.%20Diehl%2C%20and%20German%20Hodgkin%26%23039%3Bs%20Lymphoma%20Study%20Group.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fpubmed.ncbi.nlm.nih.gov%5C%2F11310450%5C%2F%26%23039%3B%26gt%3BNon-Hodgkin%26%23039%3Bs%20lymphoma%20after%20primary%20Hodgkin%26%23039%3Bs%20disease%20in%20the%20German%20Hodgkin%26%23039%3Bs%20Lymphoma%20Study%20Group%3A%20incidence%2C%20treatment%2C%20and%20prognosis%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BJournal%20of%20Clinical%20Oncology%3A%20Official%20Journal%20of%20the%20American%20Society%20of%20Clinical%20Oncology%26lt%3B%5C%2Fi%26gt%3B%2019%2C%20no.%207%20%28April%201%2C%202001%29%3A%202026%5Cu201332.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1200%5C%2FJCO.2001.19.7.2026.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Non-Hodgkin%27s%20lymphoma%20after%20primary%20Hodgkin%27s%20disease%20in%20the%20German%20Hodgkin%27s%20Lymphoma%20Study%20Group%3A%20incidence%2C%20treatment%2C%20and%20prognosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Rueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Josting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Franklin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22May%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Sieber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Breuer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Engert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Diehl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22German%20Hodgkin%27s%20Lymphoma%20Study%20Group%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20The%20cumulative%20incidence%20for%20non-Hodgkin%20lymphoma%26%23039%3Bs%20%28NHL%29%20after%20primary%20Hodgkin%26%23039%3Bs%20disease%20%28HD%29%20ranges%20between%201%25%20and%206%25.%20To%20investigate%20the%20course%20of%20disease%20for%20secondary%20NHL%2C%20we%20retrospectively%20analyzed%20patients%20treated%20within%20clinical%20trials%20of%20the%20German%20Hodgkin%26%23039%3Bs%20Lymphoma%20Study%20Group%20%28GHSG%29%20since%201981.%5CnPATIENTS%20AND%20METHODS%3A%20From%201981%20to%201998%2C%20the%20GHSG%20conducted%20three%20generations%20of%20clinical%20trials%20for%20the%20treatment%20of%20primary%20HD%20involving%20a%20total%20of%205%2C406%20patients.%20Reference%20histology%20by%20an%20expert%20panel%20was%20obtained%20for%204%2C104%20of%20the%20patients.%20Data%20on%20incidence%2C%20treatment%2C%20and%20outcome%20of%20secondary%20NHL%20were%20updated%20in%20March%201999.%5CnRESULTS%3A%20At%20first%20diagnosis%20of%20HD%2C%20the%20pathologists%20rejected%20114%20%282.1%25%29%20of%205%2C520%20cases%20initially%20diagnosed%20as%20HD%20and%20rediagnosed%20them%20as%20primary%20NHL.%20Fifty-two%20%280.9%25%29%20of%20the%20remaining%205%2C406%20patients%20developed%20a%20secondary%20NHL.%20One%20patient%20was%20excluded%20from%20further%20analyses%20because%20of%20insufficient%20documentation.%20Six%20patients%20had%20no%20further%20therapy%20because%20of%20patient%20refusal%20%28n%20%3D%201%29%20or%20rapidly%20progressive%20disease%20%28n%20%3D%205%29.%20For%20the%20remaining%2045%20patients%2C%20overall%20response%20rate%20was%2043%25%20%2836%25%20complete%20response%20and%207%25%20partial%20response%29.%20The%20actuarial%202-year%20freedom%20from%20treatment%20failure%20%28FFTF%29%20and%20overall%20survival%20%28OS%29%20for%20all%20patients%20was%2024%25%20and%2030%25%2C%20respectively%2C%20and%20for%20patients%20with%20diffuse%20large-cell%20lymphoma%2C%20it%20was%2028%25%20and%2035%25%2C%20respectively.%20Time%20of%20occurrence%20of%20secondary%20NHL%20after%20first%20diagnosis%20of%20HD%20and%20variables%20employed%20in%20the%20age-adjusted%20International%20Prognostic%20Factor%20Index%20%28IPFI%29%20significantly%20influenced%20treatment%20outcome.%5CnCONCLUSION%3A%20In%20the%20GHSG%2C%20the%20incidence%20of%20secondary%20NHL%20with%200.9%25%20is%20relatively%20low%20compared%20with%20previously%20reported%20series.%20The%20prognosis%20of%20secondary%20NHL%20seems%20dismal%20and%20is%20significantly%20influenced%20by%20time%20of%20occurrence%20and%20the%20age-adjusted%20IPFI.%20In%20a%20subset%20of%20patients%20with%20secondary%20NHL%2C%20long-term%20disease-free%20survival%20could%20be%20achieved.%22%2C%22date%22%3A%222001-04-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1200%5C%2FJCO.2001.19.7.2026%22%2C%22ISSN%22%3A%220732-183X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpubmed.ncbi.nlm.nih.gov%5C%2F11310450%5C%2F%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A31%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22B5ZHD3CF%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%22%2C%22parsedDate%22%3A%222001%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%5Cu00fcffer%2C%20Jens-Ulrich.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fd-nb.info%5C%2F980671485%26%23039%3B%26gt%3BUntersuchungen%20zur%20Langzeittoxizit%5Cu00e4t%20nach%20kurativer%20Therapie%20des%20Hodgkin-Lymphoms.%20Habilitationsschrift%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20J.%20R%5Cu00fcffer%2C%202001.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22thesis%22%2C%22title%22%3A%22Untersuchungen%20zur%20Langzeittoxizit%5Cu00e4t%20nach%20kurativer%20Therapie%20des%20Hodgkin-Lymphoms.%20Habilitationsschrift%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jens-Ulrich%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22thesisType%22%3A%22%22%2C%22university%22%3A%22J.%20R%5Cu00fcffer%22%2C%22date%22%3A%222001%22%2C%22language%22%3A%22ger%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fd-nb.info%5C%2F980671485%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222021-03-23T15%3A56%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22QN8CEQZC%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22R%5Cu00fcffer%20et%20al.%22%2C%22parsedDate%22%3A%222000-12-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BR%5Cu00fcffer%2C%20J.U.%2C%20K.%20Breuer%2C%20and%20H.%20Flechtner.%20%26quot%3B%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs007610070018%26%23039%3B%26gt%3BLebensqualit%5Cu00e4t%20und%20Lebensquantit%5Cu00e4t%20bei%20Morbus%20Hodgkin%26lt%3B%5C%2Fa%26gt%3B.%26quot%3B%20%26lt%3Bi%26gt%3BDer%20Onkologe%26lt%3B%5C%2Fi%26gt%3B%206%2C%20no.%2012%20%28December%201%2C%202000%29%3A%201189%5Cu201396.%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lebensqualit%5Cu00e4t%20und%20Lebensquantit%5Cu00e4t%20bei%20Morbus%20Hodgkin%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.U.%22%2C%22lastName%22%3A%22R%5Cu00fcffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Breuer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Flechtner%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222000-12-01%22%2C%22language%22%3A%22de%22%2C%22DOI%22%3A%2210.1007%5C%2Fs007610070018%22%2C%22ISSN%22%3A%220947-8965%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs007610070018%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A31%3A35Z%22%7D%7D%2C%7B%22key%22%3A%2275SQPW34%22%2C%22library%22%3A%7B%22id%22%3A6298796%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Josting%20et%20al.%22%2C%22parsedDate%22%3A%222000-08-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJosting%2C%20A.%2C%20U.%20Rueffer%2C%20J.%20Franklin%2C%20M.%20Sieber%2C%20V.%20Diehl%2C%20and%20A.%20Engert.%20%26%23x201C%3BPrognostic%20Factors%20and%20Treatment%20Outcome%20in%20Primary%20Progressive%20Hodgkin%20Lymphoma%3A%20A%20Report%20from%20the%20German%20Hodgkin%20Lymphoma%20Study%20Group.%26%23x201D%3B%20%26lt%3Bi%26gt%3BBlood%26lt%3B%5C%2Fi%26gt%3B%2096%2C%20no.%204%20%28August%2015%2C%202000%29%3A%201280%26%23x2013%3B86.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prognostic%20factors%20and%20treatment%20outcome%20in%20primary%20progressive%20Hodgkin%20lymphoma%3A%20a%20report%20from%20the%20German%20Hodgkin%20Lymphoma%20Study%20Group%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Josting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Rueffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Franklin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Sieber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Diehl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Engert%22%7D%5D%2C%22abstractNote%22%3A%22To%20determine%20prognostic%20factors%20and%20treatment%20outcome%2C%20patients%20with%20primary%20progressive%20Hodgkin%20lymphoma%20%28HD%29%20registered%20in%20the%20database%20of%20the%20German%20Hodgkin%20Lymphoma%20Study%20Group%20%28GHSG%29%20were%20analyzed%20retrospectively.%20Detailed%20records%20from%20randomized%20prospective%20multicenter%20trials%20performed%20between%201988%20and%201998%20of%203807%20patients%20recruited%20in%20these%20trials%20were%20reviewed.%20The%20median%20age%20of%20the%20206%20patients%20available%20was%2034%20years%20%28range%2C%2016-71%29.%20Fifty-seven%20patients%20%2828%25%29%20in%20intermediate%20stage%20and%20149%20patients%20%2872%25%29%20in%20advanced%20stage%20developed%20progressive%20disease%20%28PD%29.%20One%20hundred%20and%20fifty-three%20patients%20%2874%25%29%20were%20treated%20with%20salvage%20chemotherapy%2C%2047%20patients%20%2823%25%29%20with%20salvage%20radiotherapy%2C%20and%206%20patients%20%283%25%29%20did%20not%20receive%20any%20therapy%20due%20to%20rapid%20PD.%20Seventy%20patients%20%2834%25%29%20were%20treated%20with%20high-dose%20chemotherapy%20%28HDCT%29%20and%20autologous%20stem%20cell%20transplantation.%20The%205-year%20freedom%20from%20second%20failure%20%28FF2F%29%20and%20overall%20survival%20%28OS%29%20for%20all%20patients%20were%2017%25%20and%2026%25%2C%20respectively.%20The%205-year%20FF2F%20and%20OS%20for%20patients%20treated%20with%20HDCT%20were%2031%25%20and%2043%25%2C%20respectively.%20In%20multivariate%20analysis%20low%20Karnofsky%20performance%20score%20at%20the%20time%20of%20progression%20%28P%20%26lt%3B.0001%29%2C%20age%20above%2050%20years%20%28P%20%3D.019%29%2C%20and%20failure%20to%20attain%20a%20temporary%20remission%20on%20first-line%20treatment%20%28P%20%3D.0003%29%20were%20significant%20adverse%20prognostic%20factors%20for%20OS.%20Patients%20with%20none%20of%20these%20risk%20factors%20had%20a%205-year%20OS%20of%2055%25%20compared%20with%200%25%20for%20patients%20with%20all%203%20of%20these%20unfavorable%20prognostic%20factors.%20Although%20HDCT%20is%20a%20reasonable%20option%20for%20selected%20patients%20with%20primary%20progressive%20HD%2C%20the%20majority%20did%20not%20receive%20HDCT.%20Interestingly%2C%20salvage%20radiotherapy%20gave%20promising%20results%20in%20patients%20with%20localized%20PD.%20%28Blood.%202000%3B96%3A1280-1286%29%22%2C%22date%22%3A%222000-08-15%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%220006-4971%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2246NNKHWR%22%2C%22J987ELTY%22%5D%2C%22dateModified%22%3A%222024-03-11T11%3A31%3A30Z%22%7D%7D%5D%7D
Clayman, Marla L., Fülöp Scheibler, Jens Ulrich Rüffer, Kai Wehkamp, and Friedemann Geiger. “The Six Steps of SDM: Linking Theory to Practice, Measurement and Implementation.” BMJ Evidence-Based Medicine 29, no. 2 (March 21, 2024): 75–78. https://doi.org/10.1136/bmjebm-2023-112289.
Schwab, Isabella, Till Dresbach, Tim Ohnhäuser, Dirk Horenkamp-Sonntag, Nadine Scholten, Andreas Müller, Martin Hellmich, et al. "Pressure to provide milk among mothers of very low birth weight infants: an explorative study." BMC Pregnancy and Childbirth 24, no. 1 (February 13, 2024): 134.
Ferdinandus, J., H. Müller, C. Damaschin, A. S. Jacob, J. Meissner, F. Krasniqi, U. Mey, et al. “Impact of Individualized Treatment on Recovery from Fatigue and Return to Work in Survivors of Advanced-Stage Hodgkin’s Lymphoma: Results from the Randomized International GHSG HD18 Trial.” Annals of Oncology: Official Journal of the European Society for Medical Oncology, December 5, 2023, S0923-7534(23)05102-5. https://doi.org/10.1016/j.annonc.2023.11.014.
Scheibler, Fülöp, Friedemann Geiger, Kai Wehkamp, Marion Danner, Marie Debrouwere, Constanze Stolz-Klingenberg, Anja Schuldt-Joswig, et al. “Patient-Reported Effects of Hospital-Wide Implementation of Shared Decision-Making at a University Medical Centre in Germany: A Pre-Post Trial.” BMJ Evidence-Based Medicine, November 24, 2023, bmjebm-2023-112462. https://doi.org/10.1136/bmjebm-2023-112462.
Biller-Andorno, Nikola, Martina Breuning, Anne Brüning, Anna Geldermann, Andrea Glässel, Saskia Jünger, Birgit Hiller, et al. "Gute Praxis Erfahrungsberichte. Qualitätsanforderungen an Erfahrungsberichte im Gesundheitswesen. Positionspapier der AG Erfahrungsberichte im Gesundheitswesen im DNGK e.V." DNGK-Positionspapiere. Köln: Deutsches Netzwerk Gesundheitskompetenz DNGK, July 11, 2023.
Stolz-Klingenberg, Constanze, Claudia Bünzen, Marie Coors, Charlotte Flüh, Klarissa Hanja Stürner, Kai Wehkamp, Marla L. Clayman, et al. “Comprehensive Implementation of Shared Decision Making in a Neuromedical Center Using the SHARE TO CARE Program.” Patient Preference and Adherence 17 (2023): 131–39. https://doi.org/10.2147/PPA.S388432.
Danner, Marion, Marie Debrouwere, Anne Rummer, Kai Wehkamp, Jens Ulrich Rüffer, Friedemann Geiger, Robert Wolff, Karoline Weik, and Fueloep Scheibler. "A scattered landscape: assessment of the evidence base for 71 patient decision aids developed in a hospital setting." BMC Medical Informatics and Decision Making 22, no. 1 (February 17, 2022): 44.
Stolz-Klingenberg, Constanze, Claudia Bünzen, Marie Coors, Charlotte Flüh, Nils G. Margraf, Kai Wehkamp, Marla L. Clayman, et al. "Sustainability of large-scale implementation of shared decision making with the SHARE TO CARE program." Frontiers in Neurology 13 (2022).
Fischer, Irene, Jens Ulrich Rüffer, and Manfred E. Heim. "Tumorassoziierte Fatigue bei Immuncheckpointinhibitoren." Der Onkologe, October 5, 2021, 1–5. https://doi.org/10.1007/s00761-021-01042-2.
Wünsch, Alexander, Corinna Bergelt, Heide Götze, André Karger, Karin Oechsle, Jens Ulrich Rüffer, Dorothee Speiser, and Frank Vitinius. "Kommunikationstrainings für onkologisch tätige Ärzt*innen in Deutschland." Forum 36, no. 5 (October 1, 2021): 391–95.
Müller, Karolina, Jens G. Kuipers, Joachim Weis, Irene Fischer, Tobias Pukrop, Jens U. Rüffer, and Michael Koller. “Self-Reported Fatigue in Patients with Rheumatoid Arthritis Compared to Patients with Cancer: Results from Two Large-Scale Studies.” Rheumatology International, July 16, 2021. https://doi.org/10.1007/s00296-021-04948-7.
Wehkamp, Kai, Felicia Beatrice Kiefer, Friedemann Geiger, Fueloep Scheibler, Jens Ulrich Rueffer, Norbert Donner-Banzhoff, and Cornelia Betsch. "Enhancing Specific Health Literacy with a Digital Evidence-Based Patient Decision Aid for Hypertension: A Randomized Controlled Trial." Patient Preference and Adherence 15 (June 14, 2021): 1269–79. https://doi.org/10.2147/PPA.S311470.
Debrouwere, Marie, Anne Rummer, Divna Tafelski, Corinna Knauff, Friedemann Geiger, Kai Wehkamp, Ulrich Rüffer, Fülöp Scheibler, and Marion Danner. “Wie gut ist die Studienlage für wichtige Behandlungsentscheidungen im Krankenhaus?,” Doc21ebmPS-4–10. German Medical Science GMS Publishing House, 2021. https://doi.org/10.3205/21ebm081.
Geiger, Friedemann, Anna Novelli, Daniela Berg, Claudia Hacke, Leonie Sundmacher, Olga Kopeleva, Fülöp Scheibler, Jens Ulrich Rüffer, Christine Kuch, and Kai Wehkamp. "Klinikweite Implementierung von Shared Decision Making. Erste Ergebnisse des Kieler Innovationsprojekts zum SHARE TO CARE Programm." Dtsch Ärzteblatt 118, no. 13 (February 4, 2021): 225–26. https://doi.org/10.3238/aerztebl.m2021.0144.
Gebauer, Judith, Jens U. Rüffer, and Georg Brabant. "Cancer-Related Fatigue." In Late Treatment Effects and Cancer Survivor Care in the Young: From Childhood to Early Adulthood, edited by Jörn D. Beck, Carsten Bokemeyer, and Thorsten Langer, 157–65. Cham: Springer International Publishing, 2021.
Geiger, Friedemann, Claudia Hacke, Judith Potthoff, Fueloep Scheibler, Jens Ulrich Rueffer, Christine Kuch, and Kai Wehkamp. “The Effect of a Scalable Online Training Module for Shared Decision Making Based on Flawed Video Examples - a Randomized Controlled Trial.” Patient Education and Counseling, November 27, 2020. https://doi.org/10.1016/j.pec.2020.11.033.
Matzdorff, Axel, Jens U. Rüffer, and Oliver Meyer. "From Fatigue Surveys to Survey Fatigue - Notes from Daily Hematology Practice." Blood 136, no. Supplement 1 (November 5, 2020): 39–39.
Danner, Marion, Friedemann Geiger, Kai Wehkamp, Jens Ulrich Rueffer, Christine Kuch, Leonie Sundmacher, Tove Skjelbakken, et al. "Making shared decision-making (SDM) a reality: protocol of a large-scale long-term SDM implementation programme at a Northern German University Hospital." BMJ Open 10, no. 10 (October 1, 2020): e037575. https://doi.org/10.1136/bmjopen-2020-037575.
Kreissl, Stefanie, Horst Müller, Helen Goergen, Julia Meissner, Max Topp, Martin Sökler, Jana Markova, et al. “Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group.” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 38, no. 25 (September 1, 2020): 2839–48. https://doi.org/10.1200/JCO.19.03160.
Lohmann, Michael, and Jens Ulrich Rüffer. Wenn eine Begegnung alles verändert: Ärztinnen und Ärzte erzählen. 1. Auflage. Köln: atp Verlag, 2020.
Rüffer, Jens Ulrich. "CrF, ein Symptomkomplex mit vielen Implikationen." Im Fokus Onkologie 22, no. 6 (December 1, 2019): 73–77.
Kuipers, J. G., M. Koller, F. Zeman, K. Müller, and J. U. Rüffer. “Adhärenz Und Gesundheitskommunikationskompetenz in Bezug Auf Das Therapieergebnis Bei Patienten Mit Rheumatoider Arthritis.” Zeitschrift Fur Rheumatologie 78, no. 1 (February 2019): 74–81. https://doi.org/10.1007/s00393-018-0449-y.
Rüffer, Jens Ulrich, Hans Henning Flechtner, and Peter Borchmann. "Psychosoziale Belastung und Lebensqualität nach Morbus Hodgkin: Kein Ende der Erfassung – noch kein Anfang der patientenzentrierten Intervention?" Der Onkologe 24, no. 4 (April 1, 2018): 335–39.
Romotzky, Vanessa, Julia Strupp, Alexander Hayn, Jens Ulrich Rüffer, Judith Grümmer, and Raymond Voltz. “‘All of a Sudden, a Lot Less Still Makes It Worthwhile to Be Alive:’ Palliative Care Patients’ Views on Life.” Palliative & Supportive Care, March 8, 2018, 1–7. https://doi.org/10.1017/S1478951518000081.
Kreissl, Stefanie, C Bürkle, Jens Ulrich Rüffer, Anja Mehnert, and Peter Borchmann. "Tumorassoziierte Fatigue beim Hodgkin-Lymphom." Onkologe 4, no. 2018 (February 19, 2018): 4.
Fischer, I., J. Weis, J. U. Rüffer, M. Heim, P. Bojko, and C. Ostgathe. "Tumorassoziierte Fatigue in der Palliativsituation." Zeitschrift für Palliativmedizin 18, no. 2 (March 2017): 97–110. https://doi.org/10.1055/s-0042-124041.
Loebel, Madlen, Maren Eckey, Franziska Sotzny, Elisabeth Hahn, Sandra Bauer, Patricia Grabowski, Johannes Zerweck, et al. “Serological Profiling of the EBV Immune Response in Chronic Fatigue Syndrome Using a Peptide Microarray.” PloS One 12, no. 6 (2017): e0179124. https://doi.org/10.1371/journal.pone.0179124.
Kreissl, Stefanie, Horst Mueller, Helen Goergen, Axel Mayer, Corinne Brillant, Karolin Behringer, Teresa Veronika Halbsguth, et al. "Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group." The Lancet Oncology 17, no. 10 (October 1, 2016): 1453–62. https://doi.org/10.1016/S1470-2045(16)30093-6.
Behringer, Karolin, Helen Goergen, Horst Müller, Indra Thielen, Corinne Brillant, Stefanie Kreissl, Teresa Veronika Halbsguth, et al. “Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.” Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 34, no. 36 (20 2016): 4329–37. https://doi.org/10.1200/JCO.2016.67.7450.
Fischer, Irene, Carola Riedner, Peter Bojko, Manfred E. Heim, Jens U. Rüffer, Markus Besseler, Pia Heußner, et al. “Consultation Program for Patients with Cancer-Related Fatigue: A Systematic Evaluation of the Experiences of the Bavarian Cancer Society.” Oncology Research and Treatment 39, no. 10 (2016): 646–51. https://doi.org/10.1159/000448907.
Rüffer, J.U., and I.A. Adamietz. "Fatigue – Tumorerschöpfung." Der Onkologe 19, no. 4 (April 1, 2013): 279–89.
Aapro, M., J. Rüffer, and S. Fruehauf. "Haematological support, fatigue and elderly patients." Journal of Geriatric Oncology 3, no. 3 (July 1, 2012): 246–55. https://doi.org/10.1016/j.jgo.2012.04.004.
Horneber, Markus, Irene Fischer, Fernando Dimeo, Jens Ulrich Rüffer, and Joachim Weis. "Tumor-assoziierte Fatigue. Epidemiologie, Pathogenese, Diagnostik und Therapie." Deutsches Arzteblatt International 109, no. 9 (March 2012): 161–71; quiz 172. https://doi.org/10.3238/arztebl.2012.0161.
Zimmer, Philipp, and Jens Ulrich Rüffer. "Fatigue-Syndrom." In Sport und körperliche Aktivität in der Onkologie, edited by Freerk T. Baumann, Elke Jäger, and Wilhelm Bloch, 69–78. Berlin, Heidelberg: Springer, 2012.
Armbrecht, Axel, Andreas Gröschel, Christoph Pöttgen, Martin Reck, Jens Ulrich Rüffer, Ulf Seifart, Cornelia M. Ulrich, and Hauke Winter. "Nachsorge, Komplikationen und deren Therapie bei der operativen, strahlentherapeutischen und medikamentösen Therapie des Lungenkarzinoms." Oncology Research and Treatment 34, no. Suppl. 4 (2011): 11–16. https://doi.org/10.1159/000328515.
Rüffer, Jens-Ulrich. Gestern war ich noch einer von Euch, heute habe ich Krebs: ein Theaterstück. 1. Aufl. Köln: Atp-Verl., Gesundheit, Gesellschaft, Leben, 2011.
Kuhnt, Susanne, Jochen Ernst, Susanne Singer, Jens Ulrich Rüffer, Rolf-Dieter Kortmann, Jens-Uwe Stolzenburg, and Reinhold Schwarz. "Fatigue in Cancer Survivors – Prevalence and Correlates." Oncology Research and Treatment 32, no. 6 (2009): 312–17. https://doi.org/10.1159/000215943.
Rüffer, Jens-Ulrich. Fatigue: Hilfe bei tumorbedingter Erschöpfung. Grün-gelbe Broschürenreihe 13. Zwickau: Sächsische Krebsges, 2009.
Borchmann, P., K. Behringer, A. Josting, J. U. Rueffer, R. Schnell, V. Diehl, A. Engert, H. M. Kvasnicka, and J. Thiele. "Sekundärneoplasien nach erfolgreicher Primärtherapie des malignen Hodgkin-Lymphoms." Der Pathologe 27, no. 1 (February 1, 2006): 47–52.
Rüffer, J. U., and H. Flechtner. "Fatigue — Diagnostik, klinische Implikationen und Therapie." Der Onkologe 12, no. 1 (January 1, 2006): 36–40.
Rüffer, J. U., V. Ballova, J. Glossmann, M. Sieber, J. Franklin, L. Nogova, V. Diehl, A. Josting, and German Hodgkin Study Group. “BEACOPP and COPP/ABVD as Salvage Treatment after Primary Extended Field Radiation Therapy of Early Stage Hodgkins Disease - Results of the German Hodgkin Study Group.” Leukemia & Lymphoma 46, no. 11 (November 2005): 1561–67. https://doi.org/10.1080/10428190500178167.
Ballova, V., J.-U. Rüffer, H. Haverkamp, B. Pfistner, H. K. Müller-Hermelink, E. Dühmke, P. Worst, et al. “A Prospectively Randomized Trial Carried out by the German Hodgkin Study Group (GHSG) for Elderly Patients with Advanced Hodgkin’s Disease Comparing BEACOPP Baseline and COPP-ABVD (Study HD9elderly).” Annals of Oncology: Official Journal of the European Society for Medical Oncology 16, no. 1 (January 2005): 124–31. https://doi.org/10.1093/annonc/mdi023.
Rüffer, J. U. “Tumor-Related Fatigue - an Underestimated Problem.” Onkologie 26, no. 5 (October 2003): 423–24. https://doi.org/10.1159/000074730.
Proctor, S. J., J. U. Rueffer, B. Angus, K. Breuer, H. Flechtner, R. Jarrett, A. Levis, P. Taylor, and U. Tirelli. “Hodgkin’s Disease in the Elderly: Current Status and Future Directions.” Annals of Oncology: Official Journal of the European Society for Medical Oncology 13 Suppl 1 (2002): 133–37. https://doi.org/10.1093/annonc/13.s1.133.
Rüffer, U., M. Sieber, and V. Diehl. "Morbus Hodgkin." In Geriatrische Onkologie, edited by Klaus Höffken, Ulrich Wedding, and Gerald Kolb, 499–509. Berlin, Heidelberg: Springer, 2002.
Rueffer, U., K. Breuer, A. Josting, B. Lathan, M. Sieber, O. Manzke, F. J. Grotenhermen, et al. "Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment." Annals of Oncology: Official Journal of the European Society for Medical Oncology 12, no. 9 (September 2001): 1307–11. https://doi.org/10.1023/a:1012464703805.
Rueffer, U., A. Josting, J. Franklin, M. May, M. Sieber, K. Breuer, A. Engert, V. Diehl, and German Hodgkin's Lymphoma Study Group. "Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis." Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 19, no. 7 (April 1, 2001): 2026–32. https://doi.org/10.1200/JCO.2001.19.7.2026.
Rüffer, Jens-Ulrich. "Untersuchungen zur Langzeittoxizität nach kurativer Therapie des Hodgkin-Lymphoms. Habilitationsschrift." J. Rüffer, 2001.
Rüffer, J.U., K. Breuer, and H. Flechtner. "Lebensqualität und Lebensquantität bei Morbus Hodgkin." Der Onkologe 6, no. 12 (December 1, 2000): 1189–96.
Josting, A., U. Rueffer, J. Franklin, M. Sieber, V. Diehl, and A. Engert. “Prognostic Factors and Treatment Outcome in Primary Progressive Hodgkin Lymphoma: A Report from the German Hodgkin Lymphoma Study Group.” Blood 96, no. 4 (August 15, 2000): 1280–86.